US20110003281A1 - Device and method for multiple analyte detection - Google Patents

Device and method for multiple analyte detection Download PDF

Info

Publication number
US20110003281A1
US20110003281A1 US11/811,476 US81147607A US2011003281A1 US 20110003281 A1 US20110003281 A1 US 20110003281A1 US 81147607 A US81147607 A US 81147607A US 2011003281 A1 US2011003281 A1 US 2011003281A1
Authority
US
United States
Prior art keywords
sample
detection
chamber
chambers
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/811,476
Inventor
Timothy Woudenberg
Michael Albin
Reid B. Kowallis
Yefim Raysberg
Robert P. Ragusa
Emily S. Winn-Deen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems LLC
Applied Biosystems Inc
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34753548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110003281(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/831,983 external-priority patent/US6126899A/en
Priority claimed from US09/628,076 external-priority patent/US7235406B1/en
Application filed by Applera Corp filed Critical Applera Corp
Priority to US11/811,476 priority Critical patent/US20110003281A1/en
Assigned to BANK OF AMERICA, N.A, AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: APPLIED BIOSYSTEMS, LLC
Assigned to APPLIED BIOSYSTEMS, LLC reassignment APPLIED BIOSYSTEMS, LLC MERGER (SEE DOCUMENT FOR DETAILS). Assignors: APPLIED BIOSYSTEMS INC.
Assigned to APPLIED BIOSYSTEMS INC. reassignment APPLIED BIOSYSTEMS INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: APPLERA CORPORATION
Assigned to APPLIED BIOSYSTEMS INC. reassignment APPLIED BIOSYSTEMS INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: APPLIED BIOSYSTEMS INC.
Publication of US20110003281A1 publication Critical patent/US20110003281A1/en
Assigned to APPLIED BIOSYSTEMS, INC. reassignment APPLIED BIOSYSTEMS, INC. LIEN RELEASE Assignors: BANK OF AMERICA, N.A.
Assigned to APPLIED BIOSYSTEMS, LLC reassignment APPLIED BIOSYSTEMS, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Assignors: BANK OF AMERICA, N.A.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06Quantitative determination
    • C12Q1/08Quantitative determination using multifield media
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • B01J2219/00317Microwell devices, i.e. having large numbers of wells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00599Solution-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B01L2200/027Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0642Filling fluids into wells by specific techniques
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1805Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
    • B01L2300/1827Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using resistive heater
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • B01L2400/049Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics vacuum
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50851Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates specially adapted for heating or cooling samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/08Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00029Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
    • G01N2035/00099Characterised by type of test elements
    • G01N2035/00148Test cards, e.g. Biomerieux or McDonnel multiwell test cards
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Definitions

  • the present invention relates to devices and methods for detecting or quantifying one or more selected analytes in a sample.
  • Biochemical testing is becoming an increasingly important tool for detecting and monitoring diseases. While tests have long been known for obtaining basic medical information such as blood type and transplant compatibility, for example, advances in understanding the biochemistry underlying many diseases have vastly expanded the number of tests which can be performed. Thus, many tests have become available for various analytical purposes, such as detecting pathogens, diagnosing and monitoring disease, detecting and monitoring changes in health, and monitoring drug therapy.
  • a method for analyzing an individual sample using a single test device should provide diagnostic information for a large number of potential analytes while requiring a small amount of sample.
  • the device should be small in size while providing high-sensitivity detection for the analytes of interest.
  • the method should also require minimal sample manipulation.
  • the device will include pre-dispensed reagents for specific detection of the analytes.
  • the present invention is directed generally to a method and device for simultaneously testing a sample for the presence, absence, and/or amount of one or more selected analytes.
  • the invention includes, in one aspect, a device for detecting or quantitating one or more of a plurality of different analytes in a liquid sample.
  • the device includes a substrate which defines a sample-distribution network having (i) a sample inlet, (ii) one or more detection chambers, and (iii) channel means providing a dead-end fluid connection between each of the chambers and the inlet.
  • each chamber includes an analyte-specific reagent effective to react with a selected analyte that may be present in the sample, and detection means for detecting the signal.
  • the detection means for each chamber includes an optically transparent window through which the signal can be detected optically. In another embodiment, the detection means includes a non-optical sensor for detecting the signal.
  • the channel means of the device may be configured in numerous ways.
  • the channel means includes a single channel to which the detection chambers are connected by dead-end fluid connections.
  • the channel means includes at least two different channels, each connected to a different group of detection chambers.
  • the channel means includes an individual channel for each detection chamber.
  • the device may include a vacuum port for placing the detection chambers under vacuum prior to the addition of sample.
  • the vacuum port is connected to the channel means at a site between, and in fluid communication with, the sample inlet and the detection chambers.
  • the vacuum port is connected to the channel means at a site downstream of the detection chambers. In this configuration, the vacuum port is additionally useful for removing liquid from the channel means after the detection chambers have been filled, to help isolate the detection chambers from one another and further reduce cross-contamination.
  • the vacuum port may be incorporated in a multi-port valve (e.g., a 3-way valve) that permits the network and associated detection chambers to be exposed alternately to a vacuum source, the sample inlet, and a vent or selected gas source.
  • a multi-port valve e.g., a 3-way valve
  • the device of the invention is prepared and sealed under vacuum when manufactured, so that a vacuum port is unnecessary.
  • the device is capable of maintaining a vacuum within the sample-distribution network (low internal gas pressure, relative to the external, ambient pressure outside the device) for a time sufficient to allow a sample to be drawn into the network and distributed to the detection chambers by vacuum action.
  • the sample-distribution network may include a vacuum reservoir in fluid communication with, and downstream of, the detection chambers, for preventing the build-up of back-pressure in the network while the detection chambers are successively filled.
  • the vacuum reservoir includes a non-flowthrough cavity connected downstream of the last-filled detection chamber, for accumulating residual gas displaced from the inlet and channel means.
  • the reservoir comprises the terminal end of the channel means connected to a vacuum source, allowing residual gas displaced by the sample to be removed continuously until sample loading is complete.
  • the analyte-specific reagents in the detection chambers may be adapted to detect a wide variety of analyte classes, including polynucleotides, polypeptides, polysaccharides, and small molecule analytes, for example.
  • the analytes are selected-sequence polynucleotides
  • the analyte-specific reagents include sequence-selective reagents for detecting the polynucleotides.
  • the polynucleotide analytes are detected by any suitable method, such as polymerase chain reaction, ligase chain reaction, oligonucleotide ligation assay, or hybridization assay.
  • the analyte-specific reagents include an oligonucleotide primer pair suitable for amplifying, by polymerase chain reaction, a target polynucleotide region in the selected analyte which is flanked by sequences complementary to the primer pair.
  • the presence of target polynucleotide, as indicated by successful amplification, is detected by any suitable means.
  • the analyte-specific reagents in each detection chamber include an antibody specific for a selected analyte-antigen.
  • the analyte-specific detection reagents include an antiben for reacting with a selected analyte antibody which may be present in the sample.
  • the device includes means for regulating the temperatures of the detection chambers, preferably providing temperature control between 0 EC and 100 EC, for promoting the reaction of the sample with the detection reagents.
  • the temperature regulating means includes a conductive heating element for each detection chamber, for rapidly heating the contents of the chamber to a selected temperature.
  • the temperature control means is preferably adapted to regulate the temperatures of the detection chambers, for heating and cooling the chambers in accordance with a selected assay protocol.
  • the device may be manufactured and packaged so that the sample-distribution network (e.g., sample inlet, detection chambers, and channel means) is provided under vacuum, ready for immediate use by the user.
  • the sample-distribution network is provided under atmospheric pressure, so that the evacuation step is carried out by the end-user prior to sample loading.
  • the invention also includes a substrate containing a plurality of sample-distribution networks as described above, for testing a single sample or a plurality of samples for selected analytes.
  • the invention includes a method of making a device such as described above.
  • the invention includes a method for detecting or quantitating a plurality of analytes in a liquid sample.
  • a device of the type described above wherein the interior of the network is placed under vacuum.
  • a liquid sample is then applied to the inlet, and the sample is allowed to be drawn into the sample-distribution network by vacuum action, delivering sample to the detection chambers.
  • the delivered sample is allowed to react with the analyte-specific reagent in each detection chamber under conditions effective to produce a detectable signal when the selected analyte is present in the sample.
  • the reaction chambers are inspected or analyzed to determine the presence and/or amount of the selected analytes in the sample.
  • the device of the invention may also be provided as part of a kit which additionally includes selected reagents, sample preparation materials if appropriate, and instructions for using the device.
  • FIGS. 1A and 1B show a plan view ( 1 A) and perspective view ( 1 B) of an exemplary assay device in accordance with the invention
  • FIGS. 2A-2C illustrate several exemplary sample distribution network configurations in accordance with the invention
  • FIGS. 3A-3C illustrates a time sequence for the filling of the detection chambers of a sample-distribution network with fluid sample
  • FIG. 4 illustrates a sample-distribution network containing three sample delivery channels for delivering sample to three different sets of detection chambers
  • FIG. 5 illustrates a sample-distribution network having a separate delivery channel for each detection chamber
  • FIGS. 6A-6C illustrate selected features of another sample-distribution network in accordance with the invention; the device is shown in plan view ( 6 A), perspective view ( 6 B), with a portion of the sample distribution network of the device shown in FIG. 6C ;
  • FIG. 7 shows an exploded view of a portion of a device in accordance with the invention.
  • FIG. 8 shows an exploded view of a portion of another device in accordance with the invention.
  • FIG. 9 shows a perspective view of another device in accordance with the invention.
  • Dead-end fluid connection between a detection chamber and a sample inlet refers to a fluid connection which provides the sole fluid access to a detection chamber, such that fluid cannot enter or exit the detection chamber by any other way than through the dead-end fluid connection.
  • dead-end fluid connection refers to a channel whose cross-section is sufficiently narrow to preclude bi-directional fluid flow through the channel. That is, liquid cannot flow through the channel in one direction while air or another liquid is flowing through the channel in the opposite direction.
  • microdevice means a device in accordance with the invention.
  • the present invention provides a device which is useful for testing one or more fluid samples for the presence, absence, and/or amount of one or more selected analytes.
  • the device includes a substrate which defines a sample-distribution network having (i) a sample inlet, (ii) one or more detection chambers (preferably a plurality of detection chambers), and (iii) channel means providing a dead-end fluid connection between each of the chambers and the inlet.
  • Each chamber includes an analyte-specific reagent effective to react with a selected analyte that may be present in such sample.
  • the substrate also provides, for each chamber, an optically transparent window through which analyte-specific reaction products can be detected.
  • the detection means for each chamber comprises a non-optical sensor for signal detection.
  • the present invention provides a number of advantages in an assay for multiple analytes in a sample, as will be discussed below.
  • the invention facilitates the transition from a macro size sample to a micro-sized sample, wherein the device of the invention provides one-step metering of reagents and sample in a multi-analyte detection assay.
  • FIGS. 1A and 1B show a plan view and perspective view, respectively, of an exemplary assay device 30 in accordance with the invention.
  • Device 30 includes a substrate 32 which defines a sample-distribution network 34 .
  • the device also includes mount 36 containing a sample inlet 38 and optionally, vacuum port means 40 which is located downstream of the detection chambers.
  • Inlet 38 may be adapted to form a vacuum-tight seal with the end of a syringe, for sample loading, or with a multi-port valve to provide fluid communication with the sample and one or more liquid or gaseous fluids.
  • the inlet may further include a septum cap, if desired, for maintaining the network under vacuum and allowing introduction of sample by canula or needle.
  • Vacuum port 40 may be adapted for connection to a vacuum source, such as a vacuum pump.
  • the vacuum connection may include a valve for closing off the sample-distribution network from the vacuum source, or a multi-port valve for connection to a vacuum source and one or more selected gas supplies.
  • Substrate 30 further provides indentations or holes 42 , which may be arranged asymmetrically as illustrated in FIG. 1A , to engage corresponding pins or protrusions in a device-holder, not shown, to immobilize and orient the device for analysis.
  • distribution network 34 a includes sample inlet 38 a, a plurality of detection chambers 44 a, channel means comprising a single channel 46 a to which the detection chambers are each connected by dead-end fluid connections 48 a, and a vacuum port 40 a.
  • the detection chambers are distributed on either side of channel 46 a, with the fluid connections branching off in pairs from opposite sides of the channel.
  • FIG. 2B shows a portion of an alternative network 34 b having an inlet 38 b and detection chambers 44 b, wherein fluid connections 48 b branch off from channel 46 b in a staggered manner.
  • the detection chambers in the device of the invention may be arranged to form a repeating 2-dimensional array which facilitates indexing and identification of the various chambers, as well as allowing rapid measurement of an optical signal produced by each chamber upon reaction with the sample, if optical detection is used.
  • FIGS. 2A-2B show networks in which the detection chambers are arranged in rows and columns along perpendicular axes, allowing the chambers to be identified by X and Y indices if desired.
  • This type of array (a perpendicular array) also facilitates successive interrogations of the chambers in a chamber-by-chamber analysis mode.
  • FIG. 2C shows part of a network 34 c having inlet 38 c and an array of staggered detection chambers 44 c.
  • the detection chambers are connected to a common delivery channel 46 c by fluid connections 48 c.
  • the device may also include identifying symbols adjacent the detection chamber to facilitate identification or confirmation of the analytes being detected.
  • the detection chambers of the device are each provided with analyte-specific reagents which are effective to react with a selected analyte which may be present in the sample, as discussed further below. Reaction of the sample with the analyte-specific reagents results in production of a detectable signal which indicates that the selected analyte is present.
  • the sample is delivered to the detection chambers by vacuum action.
  • the interior of the sample-distribution network Prior to loading with sample, the interior of the sample-distribution network is placed under vacuum so that the residual gas pressure in the network is substantially below atmospheric pressure (i.e., substantially less than 760 mm Hg).
  • atmospheric pressure i.e., substantially less than 760 mm Hg.
  • FIGS. 3A-3C illustrate the filling process for a sample-distribution network 34 in accordance with FIG. 2A .
  • the network includes sample inlet 38 , detection chambers 44 , and sample delivery channel 46 which is connected to the various detection chambers by dead-end fluid connections 48 .
  • the network further includes a vacuum reservoir 40 at the terminus of the delivery channel.
  • a plurality of the detection chambers 44 contain dried detection reagents for detecting a different selected analyte in each chamber, with one or more chambers optionally being reserved as controls.
  • FIG. 3A shows the device before sample loading is initiated.
  • the network is evacuated to establish an internal pressure within the network that is substantially below atmospheric pressure (e.g., 1 to 40 mm Hg).
  • the interior of the network should also be substantially liquid-free to minimize vapor pressure problems.
  • FIG. 3B shows the network after sample fluid 50 has entered the network through inlet 38 ( FIG. 3B ).
  • the sample sequentially fills each of the detection chambers ( FIG. 3B ) until all of the chambers have been filled ( FIG. 3C ).
  • sample fluid may continue to flow through channel 46 into vacuum reservoir 40 until the reservoir becomes full or the flow is otherwise terminated (e.g., by closing a valve associated with the vacuum reservoir).
  • sample flow through the channel means does not substantially disturb the contents of the detection chambers that have already been filled, because further flow into or out of each filled detection chamber is restricted by the dead-end fluid connections, such as connections 48 .
  • Cross-contamination between different detection chambers is therefore reduced, so that erroneous signals due to cross-contamination can be avoided.
  • a further advantage of the invention is that the sample can be mixed with the analyte-specific detection reagents and detected all in the same chamber, without requiring movement of the sample from each chamber to another site.
  • the detection reagents need not be immobilized on or adhered to the inner surfaces of the detection chambers.
  • the components of the sample-distribution network are designed to ensure that an adequate volume of sample will be delivered to the detection chambers to allow accurate analyte detection and/or quantitation.
  • the percent-volume of a detection chamber that must be occupied by the sample will vary according to the requirements of the reagents and the detection system used. Typically, the volume-percent will be greater than 75%, preferably greater than 90%, and more preferably greater than 95%.
  • the volume-percent filling of the chambers is preferably greater than 95%, and more preferably is at least 99%.
  • the degree to which the detection chambers are filled with sample will generally depend upon (1) the initial ratio of the external (atmospheric) pressure to the initial pressure within the network, (2) the individual and total volumes defined by the detection chambers, (3) the volume defined by the channel means, and (4) the nature of the network downstream of the last detection chamber.
  • V s, % the percentage occupancy (volume-percent) of sample fluid in the chamber after sample loading (V s, %) will be related to the external atmospheric pressure (P ext ) and the initial internal pressure within the network before sample loading (P int ) by the expression:
  • the dimensions of the channel and dead-end fluid connections are preferably selected to define a total volume that is substantially less than the total volume defined by the detection chambers.
  • the collective volume of the channel means is less than 20% of the total collective volume of the detection chambers, and more preferably less than 5%.
  • the volume of each dead-end fluid connection should be substantially less than the volume of the associated detection chamber.
  • the volume of each dead-end connection is less than 20%, preferably less than 10%, and more preferably less than 5% of the volume of the associated detection chamber.
  • the problem of back-pressure can be further diminished by including a vacuum reservoir downstream of the last detection chamber to be filled.
  • the vacuum reservoir is a non-flowthrough cavity in which gas displaced by the sample fluid can collect.
  • the volume of the reservoir will vary according to the configuration and needs of the particular device.
  • the volume of the reservoir can be selected to be equal in volume to one or more detection chambers volumes, or alternatively, is one-to five-fold as great as the total collective volume of the channel means.
  • the vacuum reservoir is connected to a vacuum source, so that residual gas can be removed continuously until sample loading into the detection chambers is complete, as discussed further below.
  • FIG. 4 shows another sample-distribution network in accordance with the invention, wherein the channel means of the network includes at least two different sample delivery channels, each connected to a different group of detection chambers.
  • FIG. 4 shows a sample-distribution network 60 having a sample inlet 62 , three different groups of detection chambers 64 a, 64 b, and 64 c, and channel means 66 which include corresponding channels 66 a, 66 b, and 66 c associated with the three chamber groups.
  • the chambers are connected to channels 64 a - 64 c via dead-end fluid connections 68 a - 68 c, which provide uni-directional flow of the sample into the detection chambers.
  • One advantage of using multiple delivery channels is that the time needed to fill the detection chambers with the sample can be significantly reduced relative to the time needed to fill the same number of detection chambers using a single delivery channel.
  • the loading time for a network in accordance with FIG. 4 will be about one-third of that needed to fill an identical number of detection chambers via the single channel format illustrated in FIG. 2A , all other factors being equal.
  • the filling time will vary inversely with the number of delivery channels used.
  • the sample-distribution network in FIG. 4 further includes separate vacuum reservoirs 70 a - 70 c which are connected to the termini of sample delivery channels 64 a - 64 c, downstream of the detection chambers.
  • the vacuum chambers are dimensioned to help maintain a low internal gas pressure during sample loading.
  • the channel means includes an individual channel for each detection chamber, as illustrated in FIG. 5 .
  • Network 80 includes an inlet 82 , detection chambers 84 , and associated with each detection chamber, a dead-end fluid connection 86 , which may also be referred to as channel means, for delivering sample to each chamber.
  • Each dead-end fluid connection is dimensioned to define a volume that is substantially less than the volume of the associated detection chamber, to ensure that each detection chamber is sufficiently filled with sample. This embodiment provides rapid filling of the detection chambers with minimal cross-contamination.
  • the device of the invention may also include a vacuum port communicating with the sample-distribution network, for applying a vacuum to the network before or during sample loading.
  • the vacuum port is connected to the channel means at a site between, and in fluid communication with, the sample inlet and the detection chambers. An illustration of this can be found in FIG. 9 .
  • the vacuum port thus provides a convenient way to reduce the internal pressure within the network to a selected residual pressure prior to sample loading.
  • the vacuum port can be used to remove air from the space between the syringe and the inlet, before the sample is admitted into the network.
  • the vacuum port is connected to the channel means at a site downstream of the sample inlet and detection chambers (e.g., FIG. 6A ).
  • the vacuum port may additionally be used to remove liquid from the channel means after the detection chambers have been filled, to help isolate the detection chambers from one another and further reduce cross-contamination.
  • the vacuum port constitutes a part of the vacuum reservoir described above, where the reservoir includes a vacuum source linked to the terminal end of a sample delivery channel. The vacuum port may be kept open to the network during sample loading, to continuously remove residual gas from the network until all of the detection chambers have been filled.
  • the vacuum port may include a multi-port valve (e.g., 3-way valve) that permits the network and associated detection chambers to be exposed alternately to a vacuum source, the sample inlet, and a vent or gas source.
  • a valve may be used to alternately expose the network to vacuum and a selected gas source, to replace residual air with the selected gas.
  • gas replacement in the network may be useful to remove molecular oxygen (O 2 ) or other atmospheric gases which might otherwise interfere with the performance of the detection reagents.
  • Argon and nitrogen are inert gases which may be suitable for most situations.
  • Another gas which may be used is carbon dioxide (CO 2 ), which is highly soluble in water due to its ability to form carbonate and bicarbonate ions.
  • CO 2 carbon dioxide
  • the sample fluid is an aqueous solution
  • bubbles of carbon dioxide which may form in the network during sample loading may be eliminated via dissolution in the sample fluid.
  • the degree of sample filling in the detection chambers is therefore enhanced.
  • carbon dioxide should not be used if it interferes with the detection reagents.
  • a multi-port valve such as noted above can also be used to supply a gas which is required for detection of the selected analytes.
  • a gas which is required for detection of the selected analytes.
  • gases such as hydrocarbons (ethylene, methane) or nitrogenous gases, may also be introduced as appropriate.
  • the device of the invention is designed to allow testing of a sample for a large number of different analytes by optical analysis, using a device that is compact and inexpensive to prepare.
  • the device will be no larger in cross-section than the cross-section of a standard credit card ( ⁇ 5 cm ⁇ 10 cm), and will have a thickness (depth) of no greater than 2 cm. More preferably, the device occupies a volume of no greater than about 5 ⁇ 5 ⁇ 1 cm, excluding attachments for the sample inlet and any vacuum port. More preferably, the device has dimensions of no greater than about 3 cm ⁇ 2 cm ⁇ 0.3 cm. Devices smaller than this are also contemplated, bearing in mind that the device should provide adequate sensitivity and be easy for the end-user to handle.
  • the detection chambers in the device are generally designed to be as small as possible, in order to achieve high density of detection chambers.
  • the sizes and dimensions of the chambers will depend on a number of considerations.
  • the overhead cross-section of each chamber must be large enough to allow reliable measurement of the signal produced when the selected analyte is present in the sample.
  • the depths of the chambers can be tailored for the particular optical method used. For fluorescence detection, thin chambers may be desirable, to minimize quenching effects. For absorbance or chemiluminescence detection, on the other hand, a thicker chamber may be appropriate, to increase the detection signal.
  • the detection chambers will be dimensioned to hold from 0.001 ⁇ L to 10 ⁇ L of sample per chamber, and, more preferably between 0.01 ⁇ L and 2 ⁇ L.
  • the volume of each detection chamber is between about 0.1 ⁇ L and 1 ⁇ L, to allow visual confirmation that the chambers have been filled.
  • a chamber having a volume of 0.2 ⁇ L may have dimensions of 1 mm ⁇ 1 mm ⁇ 0.2 mm, where the last dimension is the chamber's depth.
  • the sample delivery channels are dimensioned to facilitate rapid delivery of sample to the detection chambers, while occupying as little volume as possible.
  • Typical cross-sectional dimensions for the channels will range from 5 ⁇ m to about 250 ⁇ m for both the width and depth.
  • the path lengths between chambers will be as short as possible to minimize the total channel volume.
  • the network is preferably substantially planar, i.e., the channel means and detection chambers in the device intersect a common plane.
  • the substrate that defines the sample-distribution network of the invention may be formed from any solid material that is suitable for conducting analyte detection.
  • Materials which may be used will include various plastic polymers and copolymers, such as polypropylenes, polystyrenes, polyimides, and polycarbonates.
  • Inorganic materials such as glass and silicon are also useful. Silicon is especially advantageous in view of its high thermal conductivity, which facilitates rapid heating and cooling of the device if necessary.
  • the substrate may be formed from a single material or from a plurality of materials.
  • the sample-distribution network is formed by any suitable method known in the art.
  • injection molding will generally be suitable to form detection chambers and connecting channels having a desired pattern.
  • silicon standard etching techniques from the semiconductor industry may be used, as described in Sze (1988), for example.
  • the device substrate is prepared from two or more laminated layers, as will be discussed below with reference to FIGS. 6A-6C to 8 .
  • the device will include one or more layers which provide an optically transparent window for each detection chamber, through which the analyte-specific signal is detected.
  • silica-based glasses, quartz, polycarbonate, or an optically transparent plastic layer may be used, for example. Selection of the particular window material depends in part on the optical properties of the material. For example, in a fluorescence-based assay, the material should have low fluorescence emission at the wavelength(s) being measured. The window material should also exhibit minimal light absorption for the signal wavelengths of interest.
  • the layer or layers defining the detection chambers are formed predominantly from a material that has high heat conductivity, such as silicon or a heat-conducting metal.
  • the silicon surfaces which contact the sample are preferably coated with an oxidation layer or other suitable coating, to render the surface more inert.
  • the metal can be coated with an inert material, such as a plastic polymer, to prevent corrosion of the metal and to separate the metal surface from contact with the sample. The suitability of a particular surface should be verified for the selected assay.
  • references to the “upper wall” of a detection chamber refer to the chamber surface or wall through which the optical signal is detected, and references to the “lower wall” of a chamber refers to the chamber surface or wall that is opposite the upper wall.
  • the detection chambers When the substrate material defining the lower wall and sides of the detection chambers is optically opaque, and detection is by absorption or fluorescence, the detection chambers will usually be illuminated and optically scanned through the same surface (i.e., the top surfaces of the chambers which are optically transparent).
  • the opaque substrate material preferably exhibits low reflectance properties so that reflection of the illuminating light back toward the detector is minimized. Conversely, a high reflectance will be desirable for detection based on light absorption.
  • the chambers can be illuminated with excitation light through the sides of the chambers (in the plane defined collectively by the detection chambers in the device), or more typically, diagonally from above (e.g., at a 45 degree angle), and emitted light is collected from above the chambers (i.e., through the upper walls, in a direction perpendicular to the plane defined by the detection chambers).
  • the substrate material exhibits low dispersion of the illuminating light in order to limit Rayleigh scattering.
  • the chambers can be illuminated through either wall (upper or lower), and the emitted or transmitted light is measured through either wall as appropriate. Illumination of the chambers from other directions will also be possible as already discussed above.
  • the absorptive and reflective properties of the substrate will be less important, provided that the substrate provides at least one optically transparent window for detecting the signal.
  • FIGS. 6A-6C illustrate a specific embodiment of a device in accordance with the invention.
  • device 100 includes a sample inlet 102 , sample-distribution network 104 , and vacuum port 106 which is connected to the terminus of network 104 .
  • Network 104 includes a perpendicular array of detection chambers 108 (7 rows ⁇ 8 columns) linked to sample delivery channel 110 via dead-end fluid connections 112 .
  • the device further includes vertical panel 114 adjacent sample inlet 102 , for attaching an identifying label to the device and as an attachment allowing the user to hold the device.
  • the detection chambers are packed closely together to increase the number of analytes which can be tested in the device.
  • Fluid connections 112 are provided in an L-shaped configuration ( FIG. 6C ) to impede fluid flow out of the chambers after sample loading, and to help isolate the contents of the chambers from each other.
  • FIGS. 6A and 6B are shown as being separated from each other by variable vertical spacing (to enhance the clarity of the figures), it will be appreciated that the chambers can be separated by equal distances in both the vertical and ho
  • FIGS. 7 and 8 illustrate two exemplary approaches for forming a testing device in accordance with FIGS. 6A-6B .
  • FIG. 7 shows two substrate layers 140 and 142 which can be brought together to form sample-distribution network 104 ( FIG. 6A ).
  • the network is defined primarily by substrate layer 140 , which contains indentations defining a sample inlet 102 (not shown), a plurality of detection chambers 108 , sample delivery channel 110 , and dead-end fluid connections 112 .
  • Contact of substrate layer 142 with the opposing face of layer 140 completes the formation of network 104 .
  • FIG. 8 shows substrate layers 150 and 152 for forming a network by another approach.
  • Substrate layer 150 contains indentations defining a plurality of detection chambers 108 .
  • Substrate layer 152 contains indentations defining sample delivery channel 110 and dead-end fluid connections 112 .
  • Network 104 can then be formed by contacting the opposing faces of the two substrate layers as in FIG. 7 .
  • the device Since the device is designed to provide a vacuum-tight environment within the sample-distribution network for sample loading, and also to provide detection chambers having carefully defined reaction volumes, it is desirable to ensure that the network and associate detection chambers do not leak. Accordingly, lamination of substrate layers to one another should be accomplished so as to ensure that all chambers and channels are well sealed.
  • the substrate layers can be sealably bonded in a number of ways.
  • a suitable bonding substance such as a glue or epoxy-type resin
  • the bonding substance may be applied to the entirety of either surface, so that the bonding substance (after curing) will come into contact with the detection chambers and the distribution network.
  • the bonding substance is selected to be compatible with the sample and detection reagents used in the assay.
  • the bonding substance may be applied around the distribution network and detection chambers so that contact with the sample will be minimal or avoided entirely.
  • the bonding substance may also be provided as part of an adhesive-backed tape or membrane which is then brought into contact with the opposing surface.
  • the sealable bonding is accomplished using an adhesive gasket layer which is placed between the two substrate layers.
  • bonding may be accomplished by any suitable method, including pressure-sealing, ultrasonic welding, and heat curing, for example.
  • the device of the invention may be adapted to allow rapid heating and cooling of the detection chambers to facilitate reaction of the sample with the analyte-detection reagents.
  • the device is heated or cooled using an external temperature-controller.
  • the temperature-controller is adapted to heat/cool one or more surfaces of the device, or may be adapted to selectively heat the detection chambers themselves.
  • the substrate material of the test device is preferably formed of a material which has high thermal conductivity, such as copper, aluminum, or silicon.
  • a substrate layer such as layer 140 in FIG. 7 may be formed from a material having moderate or low thermal conductivity, while substrate layer 142 ( FIG. 7 ) is provided as a thin layer, such that the temperature of the detection chambers can be conveniently controlled by heating or cooling the device through layer 142 , regardless of the thermal conductivity of the material of layer 142 .
  • layer 142 is provided in the form of an adhesive copper-backed tape.
  • substrate layer 142 may include resistive traces which contact regions adjacent the reaction chambers, whereby passage of electrical current through the traces is effective to heat or cool the chambers. This approach is particularly suitable for silicon-based substrates, and can provide superior temperature control.
  • Device 160 includes a network-defining substrate layer 161 and a flat substrate layer 180 for bonding with and sealing layer 161 .
  • Device 160 in FIG. 9 is distinguished from device 100 in FIG. 6A in that device 160 includes a vacuum reservoir 166 , instead of a vacuum port, at the terminus of delivery channel 170 .
  • sample inlet 162 in device 160 is conveniently adapted to operate in conjunction with inlet fitting 190 , so that evacuation of the network and sample loading can be effected from a single site with respect to the network.
  • Sample inlet 162 includes a hollow inlet cylinder 176 having an open proximal end 177 , which connects to network 164 , and an open, distal end 178 .
  • Cylinder 176 further includes an opening 179 located near the terminus of the distal end.
  • Inlet fitting 190 includes an inlet cap structure 200 and a port structure 210 appended thereto.
  • Cap structure 200 defines a hollow cylinder 202 having an open, proximal end 204 and a closed, distal end 206 .
  • the inner diameter of cylinder 202 is dimensioned to form a vacuum-tight seal when placed over inlet 162 .
  • Port structure 210 defines a vacuum port 212 and a sample port 214 .
  • Ports 212 and 214 communicate with cylinder 202 via openings 216 and 218 , respectively, which are formed in the side of cylinder 202 .
  • Fitting 190 additionally includes guide structure 220 for receiving the adjacent edge of panel 174 , to orient and guide fitting 190 when fitting 190 is fitted over and slided along inlet 162 .
  • Exemplary dimensions of a device which has been prepared in accordance with FIG. 9 are the following: detection chambers 168 , 1.2 mm ⁇ 1.2 mm ⁇ 0.75 mm; delivery channel 170 , 0.25 mm ⁇ 0.25 mm (width ⁇ depth); dead-end fluid connection 172 , 0.25 mm ⁇ 0.25 mm (width ⁇ depth); external dimensions: 22 cm ⁇ 15 cm ⁇ 1 mm (dimensions of network-defining portion, excluding inlet 162 and panel 174 ).
  • the detection chambers in the microdevice of the invention have volumes less than 10 ⁇ L, less than 2 ⁇ L, and most preferably less than or equal to 1 ⁇ L.
  • Device 160 may be prepared under ordinary atmospheric conditions by bonding a polymeric, adhesive-backed substrate layer 180 to the corresponding surface of layer 161 , to form a sealed network.
  • Inlet fitting 190 is fitted onto cylinder 176 of inlet 162 , such that openings 179 and 216 are aligned with each other.
  • Vacuum port 212 is connected to a vacuum line, and the interior of the network is evacuated for a selected time.
  • the network may be alternately flushed with a selected gas, such as carbon dioxide, and vacuum, as discussed above.
  • sample port 214 is loaded with, or placed in fluid communication with, the fluid sample.
  • the sample port is filled so that there is no air between the sample in the sample port and opening 218 .
  • fitting 190 is lowered further towards layer 161 until opening 179 is aligned with sample opening 218 , bringing the interior of the network in fluid communication with the sample.
  • the sample fills the chambers rapidly, typically in less than half a second.
  • the detection chambers are filled to a volume-percent of greater than 95%. Excess sample and residual gas collects in reservoir 166 .
  • fitting 190 is lowered further toward layer 161 in order to seal inlet 162 , thereby sealing the interior of the network from the outside atmosphere.
  • the sample is allowed to react with the detection reagents in the detection chambers, during or after which the optical signals produced in the chambers are detected.
  • the detection chamber(s) of the device may be pre-loaded with detection reagents which are specific for the selected analytes of interest.
  • the detection reagents are designed to produce an optically detectable signal via any of the optical methods noted in Section II below.
  • each detection chamber must contain substances specific for the analyte(s) to be detected in the particular chamber, other reagents necessary to produce the optical signal for detection may be added to the sample prior to loading, or may be placed at locations elsewhere in the network for mixing with the sample. Whether particular assay components are included in the detection chambers or elsewhere will depend on the nature of the particular assay, and on whether a given component is stable to drying. In general, it is preferred that as many of the detection reagents as possible are pre-loaded in the detection chambers during manufacture of the device, in order to enhance assay uniformity and minimize the assay steps conducted by the end-user.
  • the analyte to be detected may be any substance whose presence, absence, or amount is desirable to be determined.
  • the detection means can include any reagent or combination of reagents suitable to detect or measure the analyte(s) of interest. It will be appreciated that more than one analyte can be tested for in a single detection chamber, if desired.
  • the analytes are selected-sequence polynucleotides, such as DNA or RNA
  • the analyte-specific reagents include sequence-selective reagents for detecting the polynucleotides.
  • the sequence-selective reagents include at least one binding polymer which is effective to selectively bind to a target polynucleotide having a defined sequence.
  • the binding polymer can be a conventional polynucleotide, such as DNA or RNA, or any suitable analog thereof which has the requisite sequence selectivity.
  • binding polymers which are analogs of polynucleotides, such as deoxynucleotides with thiophosphodiester linkages, and which are capable of base-specific binding to single-stranded or double-stranded target polynucleotides may be used.
  • Polynucleotide analogs containing uncharged, but stereoisomeric methylphosphonate linkages between the deoxyribonucleoside subunits have been reported (Miller, 1979, 1980, 1990, Murakami, Blake, 1985a, 1985b).
  • the binding polymers may be designed for sequence specific binding to a single-stranded target molecule through Watson-Crick base pairing, or sequence-specific binding to a double-stranded target polynucleotide through Hoogstein binding sites in the major groove of duplex nucleic acid (Kornberg).
  • Kornberg A variety of other suitable polynucleotide analogs are also known.
  • the binding polymers for detecting polynucleotides are typically 10-30 nucleotides in length, with the exact length depending on the requirements of the assay, although longer or shorter lengths are also contemplated.
  • the analyte-specific reagents include an oligonucleotide primer pair suitable for amplifying, by polymerase chain reaction, a target polynucleotide region of the selected analyte which is flanked by 3′-sequences complementary to the primer pair.
  • the primer pair is reacted with the target polynucleotide under hybridization conditions which favor annealing of the primers to complementary regions of opposite strands in the target.
  • the reaction mixture is then thermal cycled through several, and typically about 20-40, rounds of primer extension, denaturation, and primer/target sequence annealing, according to well-known polymerase chain reaction (PCR) methods (Mullis, Saiki).
  • PCR polymerase chain reaction
  • both primers for each primer pair are pre-loaded in each of the respective detection chambers, along with the standard nucleotide triphosphates, or analogs thereof, for primer extension (e.g., ATP, CTP, GTP, and TTP), and any other appropriate reagents, such as MgCl 2 or MnCl 2 .
  • a thermally stable DNA polymerase such as Taq, Vent, or the like, may also be pre-loaded in the chambers, or may be mixed with the sample prior to sample loading.
  • Other reagents may be included in the detection chambers or elsewhere as appropriate.
  • the detection chambers may be loaded with one primer from each primer pair, and the other primer (e.g., a primer common to all of detection chambers) may be provided in the sample or elsewhere.
  • the sample is preferably pre-treated with a DNA- or RNA-polymerase prior to sample loading, to form double-stranded polynucleotides for subsequent amplification.
  • amplified sequences may be detected in double-stranded form by including an intercalating or cross-linking dye, such as ethidium bromide, acridine orange, or an oxazole derivative, for example, which exhibits a fluorescence increase or decrease upon binding to double-stranded nucleic acids (Sambrook, 1989; Ausubel; Higuchi, 1992, 1993; Ishiguro, 1995).
  • an intercalating or cross-linking dye such as ethidium bromide, acridine orange, or an oxazole derivative, for example, which exhibits a fluorescence increase or decrease upon binding to double-stranded nucleic acids
  • the level of amplification can also be measured by fluorescence detection using a fluorescently labeled oligonucleotide, such as disclosed in Lee et al. (1993) and Livak et al. (1995).
  • the detection reagents include a sequence-selective primer pair as in the more general PCR method above, and in addition, a sequence-selective oligonucleotide (FQ-oligo) containing a fluorescer-quencher pair.
  • the primers in the primer pair are complementary to 3′-regions in opposing strands of the target analyte segment which flank the region which is to be amplified.
  • the FQ-oligo is selected to be capable of hybridizing selectively to the analyte segment in a region downstream of one of the primers and is located within the region to be amplified.
  • the fluorescer-quencher pair includes a fluorescer dye and a quencher dye which are spaced from each other on the oligonucleotide so that the quencher dye is able to significantly quench light emitted by the fluorescer at a selected wavelength, while the quencher and fluorescer are both bound to the oligonucleotide.
  • the FQ-oligo preferably includes a 3′-phosphate or other blocking group to prevent terminal extension of the 3′-end of the oligo.
  • the fluorescer and quencher dyes may be selected from any dye combination having the proper overlap of emission (for the fluorescer) and absorptive (for the quencher) wavelengths while also permitting enzymatic cleavage of the FQ-oligo by the polymerase when the oligo is hybridized to the target.
  • Suitable dyes such as rhodamine and fluorscein derivatives, and methods of attaching them, are well known and are described, for example, in Menchen et al. (1993, 1994), Bergot et al. (1991), and Fung et al. (1987).
  • the fluorescer and quencher dyes are spaced close enough together to ensure adequate quenching of the fluorescer, while also being far enough apart to ensure that the polymerase is able to cleave the FQ-oligo at a site between the fluorescer and quencher.
  • spacing of about 5 to about 30 bases is suitable, as generally described in Livak et al. (1995).
  • the fluorescer in the FQ-oligo is covalently linked to a nucleotide base which is 5′ with respect to the quencher.
  • the primer pair and FQ-oligo are reacted with a target polynucleotide (double-stranded for this example) under conditions effective to allow sequence-selective hybridization to the appropriate complementary regions in the target.
  • the primers are effective to initiate extension of the primers via DNA polymerase activity.
  • the polymerase encounters the FQ-probe downstream of the corresponding primer, the polymerase cleaves the FQ-probe so that the fluorescer is no longer held in proximity to the quencher. The fluorescence signal from the released fluorescer therefore increases, indicating that the target sequence is present.
  • the detection reagents may include two or more FQ-oligos having distinguishable fluorescer dyes attached, and which are complementary for different-sequence regions which may be present in the amplified region, e.g., due to heterozygosity (Lee, 1993).
  • the detection reagents include first and second oligonucleotides effective to bind selectively to adjacent, contiguous regions of a target sequence in the selected analyte, and which may be ligated covalently by a ligase enzyme or by chemical means (Whiteley, 1989; Landegren, 1988) (oligonucleotide ligation assay, OLA).
  • a ligase enzyme or by chemical means
  • OLA oligonucleotide ligation assay
  • the two oligos can be joined by ligation, e.g., by treatment with ligase.
  • the detection wells are heated to dissociate unligated probes, and the presence of ligated, target-bound probe is detected by reaction with an intercalating dye or by other means.
  • the oligos for OLA may also be designed so as to bring together a fluorescer-quencher pair, as discussed above, leading to a decrease in a fluorescence signal when the analyte sequence is present.
  • the concentration of a target region from an analyte polynucleotide can be increased, if necessary, by amplification with repeated hybridization and ligation steps.
  • Simple additive amplification can be achieved using the analyte polynucleotide as a target and repeating denaturation, annealing, and ligation steps until a desired concentration of the ligated product is achieved.
  • the ligated product formed by hybridization and ligation can be amplified by ligase chain reaction (LCR), according to published methods (Winn-Deen).
  • LCR ligase chain reaction
  • two sets of sequence-specific oligos are employed for each target region of a double-stranded nucleic acid.
  • One probe set includes first and second oligonucleotides designed for sequence-specific binding to adjacent, contiguous regions of a target sequence in a first strand in the target.
  • the second pair of oligonucleotides are effective to bind (hybridize) to adjacent, contiguous regions of the target sequence on the opposite strand in the target.
  • the target sequence is amplified exponentially, allowing small amounts of target to be detected and/or amplified.
  • the oligos for OLA or LCR assay bind to adjacent regions in a target polynucleotide which are separated by one or more intervening bases, and ligation is effected by reaction with (i) a DNA polymerase, to fill in the intervening single stranded region with complementary nucleotides, and (ii) a ligase enzyme to covalently link the resultant bound oligonucleotides (Segev, 1992, 1994).
  • the target sequences can be detected on the basis of a hybridization-fluorescence assay (Lee et al., 1993).
  • the detection reagents include a sequence-selective binding polymer (FQ-oligo) containing a fluorescer-quencher pair, as discussed above, in which the fluorescence emission of the fluorescer dye is substantially quenched by the quencher when the FQ-oligo is free in solution (i.e., not hybridized to a complementary sequence).
  • Hybridization of the FQ-oligo to a complementary sequence in the target to form a double-stranded complex is effective to perturb (e.g., increase) the fluorescence signal of the fluorescer, indicating that the target is present in the sample.
  • the binding polymer contains only a fluorescer dye (but not a quencher dye) whose fluorescence signal either decreases or increases upon hybridization to the target, to produce a detectable signal.
  • the detection reagents in the various detection chambers should have substantially the same reaction kinetics. This can generally be accomplished using oligonucleotides and primers having similar or identical melting curves, which can be determined by empirical or experimental methods as are known in the art.
  • the analyte is an antigen
  • the analyte-specific reagents in each detection chamber include an antibody specific for a selected analyte-antigen. Detection may be by fluorescence detection, agglutination, or other homogeneous assay format.
  • antibody is intended to refer to a monoclonal or polyclonal antibody, an Fc portion of an antibody, or any other kind of binding partner having an equivalent function.
  • the antibody may be labeled with a fluorescer compound such that specific binding of the antibody to the analyte is effective to produce a detectable increase or decrease in the compound's fluorescence, to produce a detectable signal (non-competitive format).
  • the detection means includes (i) an unlabeled, analyte-specific antibody, and (ii) a fluorescer-labeled ligand which is effective to compete with the analyte for specifically binding to the antibody. Binding of the ligand to the antibody is effective to increase or decrease the fluorescence signal of the attached fluorescer.
  • the measured signal will depend on the amount of ligand that is displaced by analyte from the sample.
  • Exemplary fluorescence assay formats which may be adapted for the present invention can be found in Ullman (1979, 1981) and Yoshida (1980), for example.
  • the analyte-specific detection reagents include an antigen for reacting with a selected analyte antibody which may be present in the sample.
  • the reagents may be adapted for a competitive or non-competitive type format, analogous to the formats discussed above.
  • the analyte-specific reagents include a mono- or polyvalent antigen having one or more copies of an epitope which is specifically bound by the antibody-analyte, to promote an agglutination reaction which provides the detection signal.
  • the selected analytes are enzymes
  • the detection reagents include enzyme-substrate molecules which are designed to react with specific analyte enzymes in the sample, based on the substrate specificities of the enzymes.
  • detection chambers in the device each contain a different substrate or substrate combination, for which the analyte enzyme(s) may be specific. This embodiment is useful for detecting or measuring one or more enzymes which may be present in the sample, or for probing the substrate specificity of a selected enzyme.
  • Particularly preferred detection reagents include chromogenic substrates such as NAD/NADH, FAD/FADH, and various other reducing dyes, for example, useful for assaying hydrogenases, oxidases, and enzymes that generate products which can be assayed by hydrogenases and oxidases.
  • chromogenic substrates such as NAD/NADH, FAD/FADH, and various other reducing dyes, for example, useful for assaying hydrogenases, oxidases, and enzymes that generate products which can be assayed by hydrogenases and oxidases.
  • esterase or hydrolase e.g., glycosidase
  • the analytes are drug candidates
  • the detection reagents include a suitable drug target or an equivalent thereof, to test for binding of the drug candidate to the target.
  • this concept can be generalized to encompass screening for substances that interact with or bind to one or more selected target substances.
  • the assay device can be used to test for agonists or antagonists of a selected receptor protein, such as the acetylcholine receptor.
  • the assay device can be used to screen for substrates, activators, or inhibitors of one or more selected enzymes.
  • the assay may also be adapted to measure dose-response curves for analytes binding to selected targets.
  • the sample or detection reagents may also include a carrier protein, such as bovine serum albumin (BSA) to reduce non-specific binding of assay components to the walls of the detection chambers.
  • a carrier protein such as bovine serum albumin (BSA) to reduce non-specific binding of assay components to the walls of the detection chambers.
  • BSA bovine serum albumin
  • the analyte-specific detection reagents are preferably dispensed into the detection chambers robotically using a dispensing system designed to deliver small volumes of liquid solutions (e.g., 0.1 to 1 ⁇ L).
  • the system is supplied with separate analyte-specific detection reagents which are dispensed to pre-selected detection chambers without cross-contamination.
  • a reagent loading device that has been prepared in accordance with the invention includes a dispensing robot (Asymtek Automove 402 ) coupled to a plurality of drop-on-demand ink-jet printing heads.
  • the robot includes an X,Y-axis work table (12 inch ⁇ 12 inch) having a lateral resolution of 0.001 inch, a lateral velocity of 0-20 inch/sec, a Z-axis resolution of 0.001 inch, and a Z-axis velocity of 0-8 inch/sec.
  • the robot optionally includes a tip locator, offset camera, strobe drop camera, on-axis camera, and/or gravimetric drop calibration.
  • the printing heads are of a drop-on-demand, piezo-electric type, having wetted surfaces usually selected from glass, Teflon?, and polypropylene.
  • the minimum drop volume is 25 nL, and the maximum flow is 1 ⁇ L/min.
  • Reagent loading is preferably accomplished under carefully-controlled sterile conditions using one or more dedicated dispensing robots. After application, the reagents are allowed to dry in the chambers until most or all of the solvent has evaporated. Drying may be accelerated by baking or reduced pressure as appropriate. The detection chambers are then sealed by bonding the chamber containing substrate layer with an appropriate cover layer, and the device is ready for use.
  • the signal produced by reaction of the analyte-specific reagents with the sample is measured by any suitable detection means, including optical and non-optical methods.
  • detection may be accomplished using any optical detector that is compatible with the spectroscopic properties of the signal.
  • the assay may involve an increase in an optical signal or a decrease.
  • the optical signal may be based on any of a variety of optical principals, including fluorescence, chemiluminescence, light absorbance, circular dichroism, optical rotation, Raman scattering, radioactivity, and light scattering.
  • the optical signal is based on fluorescence, chemiluminescence, or light absorbance.
  • the optical signal to be detected will involve absorbance or emission of light having a wavelength between about 180 nm (ultraviolet) and about 50 ⁇ m (far infrared). More typically, the wavelength is between about 200 nm (ultraviolet) and about 800 nm (near infrared).
  • a variety of detection apparatus for measuring light having such wavelengths are well known in the art, and will typically involve the use of light filters, photomultipliers, diode-based detectors, and/or charge-coupled detectors (CCD), for example.
  • the optical signals produced in the individual detection chambers may be measured sequentially by iteratively scanning the chambers one at a time or in small groups, or may be measured simultaneously using a detector which interrogates all of the detection chambers continuously or at short time intervals.
  • the signals are recorded with the aid of a computer capable of displaying instantaneously (in real-time) the signal level in each of the detection chambers, and also storing the time courses of the signals for later analysis.
  • the optical signal in each chamber may be based on detection of light having one or more selected wavelengths with defined band-widths (e.g., 500 nm ⁇ 5 nm).
  • the optical signal may be based on the shape or profile of emitted or absorbed light in a selected wavelength range.
  • the optical signal will involve measurement of light having at least two distinctive wavelengths in order to include an internal control. For example, a first wavelength is used to measure the analyte, and a second wavelength is used to verify that the chamber is not empty or to verify that a selected reagent or calibration standard is present in the detection chamber. An aberration or absence of the signal for the second wavelength is an indication that the chamber may be empty, that the sample was improperly prepared, or that the detection reagents are defective.
  • a detection assembly was prepared for fluorescence detection of target polynucleotides in a sample using a device in accordance with the invention.
  • the assembly includes a translation stage for positioning the test device.
  • the test device includes a 7 ⁇ 7 array of addressable detection chambers containing fluorescent detection reagents.
  • the detector in the assembly consists of a tungsten bulb (or quartz halogen bulb, 75 W) illumination source, a CCD camera, and appropriate focusing/collection optics.
  • the illumination source is positioned so as to illuminate the device diagonally from above (e.g., at an inclination angle of 45 degrees with respect to the illuminated surface).
  • the optics include two lenses separated by an emission filter. The first lens collimates the incoming image for the emission filter, and the second lens which re-images the filtered beam onto the CCD.
  • the test device is placed at the focal point of the first lens.
  • the CCD is a thermoelectrically cooled, instrumentation-grade front-illuminated CCD (Princeton Instruments TEA/CCD-512TK/1).
  • the detection plate of the CCD has a 512 ⁇ 512 array of 27 ⁇ m square pixels which covers the entire overhead cross-section of the test device.
  • the camera head is controlled by a controller (Princeton Instruments ST-135) which communicates with a computer (Quadra 650, Apple Computers) for collecting and processing the signal data.
  • the system is capable of on-chip binning of the pixels. For detection chambers having an overhead cross-section of 1 mm ⁇ 1 mm, bins having a size of 2 ⁇ 2 pixels are suitable. More generally, the bin size is selected on the basis of the total processing time that will be required, the sizes and number of detection chambers, sensitivity, and signal noise.
  • the computer in the assembly includes signal-processing software for selecting an appropriate sub-region in each detection chamber from which the signal is measured. Such sub-regions are selected for uniformity of incoming light, to ensure that edge regions are excluded.
  • the signal image of the device is recorded and stored at selected intervals, according to the requirements of the assay.
  • the signal for each detection chamber is recorded as an average signal per bin for the selected sub-region in each chamber, since the size of the selected sub-region in each chamber will usually differ from chamber to chamber.
  • the detector optics may further be adapted to include a filter wheel for detecting fluorescence at 2 or more wavelengths.
  • the temperature of the detection chambers may be controlled, if appropriate, by any of a number of suitable methods.
  • the heating means is external to the test device (off-chip heating), and includes a temperature controller (Marlow Industries model SE 5020) equipped with a peltier device (ITI Ferro Tec model 6300) having a ramp rate of about ⁇ 4 E/sec in the range of 55 EC to 95 EC.
  • the assembly can be modified to provide one or two zones of resistance heating capable of establishing a maximum power dissipation of 25 W over a 200 mm 2 area; this mode can provide a ramp rate of ⁇ 10 E/sec during transition from 55 EC to 95 EC.
  • detection IIB for detecting an analyte-related signal in each chamber, including the optical window associated with that chamber, is also referred to herein collectively as detection means for detecting such signal.
  • Another type of detection means is a biosensor device capable of detecting the reaction of an analyte with an analyte-specific reagent in each chamber.
  • Amperometric biosensors suitable for use in the invention operate on a variety of principles.
  • the analyte being measured is itself capable of interacting with an analyte-specific reagent to generate an electrochemical species, i.e., a species capable of function as an electron donor or acceptor when in contact with an electrode.
  • an electrochemical species i.e., a species capable of function as an electron donor or acceptor when in contact with an electrode.
  • reaction of the analyte cholesterol with the reagent cholesterol oxidase generates the electrochemical species H 2 O 2 which, in contact with an electrode, produces a measurable current in a circuit containing the electrode.
  • the analyte-specific reagent may be localized on a film separated from the electrode surface by a permselective layer that is selectively permeable to the electrochemical species (and other small components in the sample).
  • a permselective layer that is selectively permeable to the electrochemical species (and other small components in the sample).
  • the analyte-specific reagent may be a receptor which is specific for the analyte. Initially, the receptor sites are filled with an analyte-enzyme conjugate. In the presence of analyte, the conjugates are displaced from the receptor, and are then free to migrate to positions close to the electrode, for production of transient electrochemical species (such as H 2 O 2 in the presence of catalase) in the vicinity of the electrode.
  • transient electrochemical species such as H 2 O 2 in the presence of catalase
  • Another general type of biosensor employs a lipid bilayer membrane as a gate for electrochemical species interposed between a sample-fluid chamber and an electrode.
  • the bilayer is provided with ion-channel proteins which function as ion gates that can be opened by analyte binding to the proteins.
  • binding of analyte to the channel proteins leads to ion flow across the membrane and detectable signal at the electrode.
  • Thin-film biosensors of the type mentioned above may be formed in a microchip or small-substrate format by photolithographic methods, such as described in U.S. Pat. Nos. 5,391,250, 5,212050, 5,200,051, and 4,975,175.
  • the chamber walls in the substrate may serve as the substrate for deposition of the required electrode and film layers.
  • suitable conductive connectors connecting the electrodes to electrical leads are also laid down.
  • each chamber contains a biosensor for a given analyte.
  • the multiple sample analytes are then separately measured in the chambers, with the results being reported to a processing unit to which the device is electrically connected.
  • the invention includes a method for detecting or quantitating a plurality of analytes in a liquid sample.
  • a device of the type described above wherein the interior of the network is placed under vacuum.
  • a liquid sample is then applied to the inlet, and the sample is allowed to be drawn into the sample-distribution network by vacuum action, delivering sample to the detection chambers.
  • the delivered sample is allowed to react with the analyte-specific reagent in each detection chamber under conditions effective to produce a detectable signal when the selected analyte is present in the sample.
  • the reaction chambers are inspected or analyzed to determine the presence and/or amount of the selected analytes in the sample.
  • the sample tested may be from any source which can be dissolved or extracted into a liquid that is compatible with the device, and which may potentially contain one or more of the analytes of interest.
  • the sample may be a biological fluid such as blood, serum, plasma, urine, sweat, tear fluid, semen, saliva, cerebral spinal fluid, or a purified or modified derivative thereof.
  • the sample may also be obtained from a plant, animal tissue, cellular lysate, cell culture, microbial sample, or soil sample, for example.
  • the sample may be purified or pre-treated if necessary before testing, to remove substances that might otherwise interfere with analyte detection.
  • the sample fluid will be an aqueous solution, particularly for polar analytes such as polypeptides, polynucleotides, and salts, for example.
  • the solution may include surfactants or detergents to improve analytes solubility.
  • organic solvents may be more suitable.
  • the device may be manufactured and sold in a form wherein the sample-distribution network is under vacuum, so that the device is ready to load by the end-user.
  • evacuation of the network is conducted by the user, through a vacuum port or via the sample inlet itself.
  • any gas in the network may be replaced with another gas, according to the requirements of the assay.
  • the residual gas is replaced with carbon dioxide, so that any gas bubbles that appear in the network after sample loading are quickly dissolved by the sample fluid, particularly if the sample is an aqueous solution.
  • the sample delivery channels in the device may be cleared of sample after the detection chambers have been filled, to further isolate the detection chambers from each other.
  • the invention also contemplates filling the delivery channels with an additional fluid, such as a mineral oil or a viscous polymer solution containing agarose or other viscous material (e.g., see Dubrow, U.S. Pat. No. 5,164,055, and Menchen et al., U.S. Pat. No. 5,290,418), to segregate the chambers from each other, or with a reagent-containing solution which facilitates the assay.
  • an additional fluid such as a mineral oil or a viscous polymer solution containing agarose or other viscous material
  • a large-volume syringe can be used to generate a vacuum inside the sample distribution network of the device prior to loading.
  • large-volume is meant that the volume of the syringe is greater than the total internal volume of the device (i.e., of the sample distribution network).
  • the volume of the syringe is at least 20-fold greater than the interior volume of the device.
  • the inlet-tip of the syringe is connected to vacuum port 212 .
  • opening 216 is aligned with opening 179 , the syringe is used to draw air from the interior of the device, thereby lowering the internal pressure.
  • an initial internal pressure of 760 torr can be reduced to less than 2 torr.
  • the syringe can be connected to fitting 106 or 102 using appropriate connections, to withdraw air from the distribution network.
  • the present invention includes a kit comprising (i) a device as described above and (ii) a syringe for drawing air from the interior of the device.
  • the invention also includes a method of using the kit to detect one or more analytes in a sample, as described above. It will be appreciated that using a syringe greatly simplifies the step of creating a vacuum inside the device, so that the device can be used quickly or immediately without needing a mechanical vacuum pump.
  • the present invention can be used in a wide variety of applications.
  • the invention can be used for medical or veterinary purposes, such as detecting pathogens, diagnosing or monitoring disease, genetic screening, determining antibody or antigen titers, detecting and monitoring changes in health, and monitoring drug therapy.
  • the invention is also useful in a wide variety of forensic, environmental, and industrial applications, including screening drug candidates for activity.
  • the present invention provides a convenient method for simultaneous assay of multiple analytes in a sample.
  • the invention is highly flexible in its applications, being adaptable to analysis of a wide variety of analytes and sample materials.
  • the invention eliminates the need for complicated and time-consuming reagent preparation.
  • the detection chambers can be loaded via a single sample inlet.
  • the use of uniformly sized detection chambers renders the device self-metering, in that a precise volume of sample is delivered to each chamber.
  • the precision, accuracy, and reproducibility of the assay are all enhanced, since the quantities and compositions of the analyte-specific reagents, the quantity of sample in the chambers, and the reaction conditions can be carefully controlled.
  • very small volumes of sample are required since the dimensions of the sample-distribution network in the device can be very small.
  • the device may be formed from a wide variety of materials, allowing the composition of the device to be adapted to the particular reagents and conditions in the assay. Inasmuch as the device requires no moving parts, and can be relatively small in size (typically having dimension on the order of millimeters to centimeters), manufacture of the device is simplified and costs are reduced.
  • the assay components for PCR detection were obtained from PE Applied Biosystems (Foster City, Calif., ⁇ -actin kit, part #N808-0230).
  • the kit components included the following stock solutions:
  • a flat substrate layer 180 and a substrate layer 161 were formed from polycarbonate by standard injection-molding methods (substrate layer 161 ) or from sheet stock (layer 180 ).
  • the volume of each detection chamber was 1 ⁇ L.
  • Detection chambers were loaded with different amounts of forward primer, reverse primer, and fluorescent probe as follows. To a polypropylene tube was added 0.5 mL each of ⁇ -actin forward primer solution, reverse primer solution, and fluorescent probe, to give a final primer/probe stock solution volume of 1.5 mL. This solution was then loaded into alternating detection chambers in substrate layer 161 using a robotically controlled microsyringe.
  • alternate chambers were loaded with either a 1 ⁇ , 5 ⁇ or 10 ⁇ amount of primer/probe solution, with 1 ⁇ (14 nL primer/probe stock solution) being equivalent to a final concentration in a detection chamber of 15 nM of each primer and 10 nM of fluorescent probe (after the dried chamber is subsequently filled with sample), 5 ⁇ (72 nL primer/probe stock solution) being equivalent to a final concentration of 75 nM of each primer and 50 nM of fluorescent probe, and 10 ⁇ (145 nL primer/probe stock solution) being equivalent to a final concentration of 150 nM of each primer and 100 nM of fluorescent probe.
  • the amounts of primer and probe in the loaded chambers corresponded to 1/20, 1 ⁇ 4, and 1 ⁇ 2 of the concentrations used under standard reaction conditions, for the 1 ⁇ , 5 ⁇ , and 10 ⁇ chambers, respectively.
  • the loaded chambers produced a “checkerboard” pattern in substrate layer 161 where each loaded chamber was separated by an intervening empty chamber.
  • the loaded substrate layer ( 161 ) was joined to a flat substrate layer 180 by ultrasonic welding.
  • Inlet fitting 190 was then placed over sample inlet 162 , such that opening 179 was aligned with vacuum port opening 216 .
  • the sample distribution network 164 and detection chambers 168 were evacuated via vacuum port 212 , which was connected to a vacuum pump, to a final internal pressure of approximately 1 to 10 torr.
  • the PCR reaction mixture (sample), without primers and probe, was prepared from the above stock solutions to give the following final concentrations in the sample:
  • a micropipette loaded with the above sample solution was placed in sample port 214 so as to minimize the deadvolume occupied by air at the tip of the pipette.
  • Inlet fitting 190 was then pressed down further to align opening 179 with opening 218 , so that the sample was drawn from port 214 into the detection chambers by vacuum action. Filling of the chambers was complete in less than a second.
  • microdevice was then clamped to a pettier device (20 mm ⁇ 20 mm) glued to an aluminum heat sink. Cycling was controlled using a Marlow temperature controller (Marlow Industries Inc., Dallas, Tex., Model No. SE 5020). A thermistor was attached to the peltier device to provide temperature feedback (Marlow part No. 217-2228-006).
  • the microdevice was thermocycled as follows:
  • Signal detection was accomplished using a fluorescence detection instrument consisting of a tungsten bulb for illumination and a CCD camera and 4-color filter wheel for detection. Images of all detection chambers (wells) were taken at the end of each thermocycle (during the 60 EC step) at several wavelengths in order to monitor the increase of the reporter's fluorescence. Interfering fluorescence fluctuations were normalized by dividing the emission intensity of the reporter dye by the emission intensity of the passive reference (ROX dye) for a given chamber. The excitation wavelength was 488 nm. The reporter intensity was measured at 518 nm, and the passive reference intensity was measured at 602 nm.
  • ROX dye passive reference
  • the highest final fluorescence signals were obtained in detection chambers loaded with a 10 ⁇ amount of primers and probe, with detectable signals appearing after about 23 cycles.
  • the 5 ⁇ chambers also showed detectable signals after cycle 23 , but the final fluorescence signal was not as high as that for the 10 ⁇ wells (due to lower probe concentration).
  • the ⁇ -actin gene was readily detected using primer and probe concentrations equal to 1 ⁇ 4 and 1 ⁇ 2 of those used under ordinary conditions.
  • the results also show that the preloaded primers and probes were successfully dissolved in the sample after sample loading.

Abstract

The invention is directed to a method and device for simultaneously testing a sample for the presence, absence, and/or amounts of one or more of a plurality of selected analytes. The invention includes, in one aspect, a device for detecting or quantitating a plurality of different analytes in a liquid sample. Each chamber may include an analyte-specific reagent effective to react with a selected analyte that may be present in the sample, and detection means for detecting the signal. Also disclosed are methods utilizing the device.

Description

  • This application is a continuation application of U.S. patent application Ser. No. 11/029,968, filed Jan. 5, 2005, which is a continuation application of U.S. patent application Ser. No. 09/628,076, filed Jul. 28, 2000, which is a continuation application of U.S. patent application Ser. No. 08/831,983, filed Apr. 2, 1997, now U.S. Pat. No. 6,126,899, which claims the benefit of prior Provisional Application No. 60/014,712, filed Apr. 3, 1996, all of which are incorporated herein in their entireties by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to devices and methods for detecting or quantifying one or more selected analytes in a sample.
  • REFERENCES
    • Ausubel, F. M., et al., Current Protocols in Molecular Biology, John Wiley & Sons, Inc., Media, Pa.
    • Bergot, J. B., et al., PCT Pub. No. WO 91/05060 (1991).
    • Blake, et al., Biochemistry 24:6132 (1985a).
    • Blake, et al., Biochemistry 24:6139 (1985b).
    • Buchardt, O., et al., PCT Pub. No. WO 92/20703 (1992).
    • Froehler, et al., Nucl. Acids Res. 16:4831 (1988).
    • Fung, S., et al., EPO Pub. No. 233,053 A2 (1987).
    • Higuchi, R., et al., Bio/Technology 10:413 (1992).
    • Higuchi, R., et al., Bio/Technology 11:1026 (1993).
    • Ishiguro, T., et al., Anal. Biochem. 229:207 (1995).
    • Kornberg, A., et al., DNA Replication, pp 46-47, W.H. Freeman and Co., New York (1992).
    • Landegren, U., et al., Science 241:1077 (1988).
    • Lee, L. G., et al. Nucl. Acids Res. 21:3761 (1993).
    • Livak, K. J., et al. PCR Methods and Applications 4:357 (1995).
    • Menchen, S. M., et al., U.S. Pat. No. 5,188,934 (1993).
    • Menchen, S. M., et al., PCT Pub. No. WO 94/05688 (1994).
    • Miller, P. S., et al, Biochemistry 18:5134 (1979).
    • Miller, P. S., et al., J. Biol. Chem. 255:6959 (1980).
    • Miller, P. S., et al., Bioconj. Chem. 1:187 (1990).
    • Mullis, K., U.S. Pat. No. 4,683,202 (1987).
    • Murakami, et al., Biochemistry 24:4041 (1985).
    • Saiki, R. K., et al., Science 230:1350 (1985).
    • Sambrook, J., et al., Molecular Cloning, 2nd Ed., Cold Spring Harbor Laboratory Press, NY (1989).
    • Segev, D., PCT Pub. No. WO 90/01069 (1990).
    • Segev, D., “Amplification of Nucleic Acid Sequences by the Repair Chain Reaction” in Nonradioactive Labeling and detection of Biomolecules, C. Kessler (Ed.), Springer Laboratory, Germany (1992).
    • Stirchak, E. P., et al., Org. Chem. 52:4202 (1987).
    • Sze, S. M., ed., VLSI Technology, 2nd Ed., McGraw-Hill Pub., New York, N.Y. (1988).
    • Ullman, E. F., U.S. Pat. No. 4,161,515 (1979).
    • Ullman, E. F., et al., U.S. Pat. No. 4,261,968 (1981).
    • Whiteley, N. M., et al., U.S. Pat. No. 4,883,750 (1989).
    • Winn-Deen, E., et al., Clin. Chem. 37: 1522 (1991).
    • Yoshida, et al., U.S. Pat. No. 4,233,401 (1980).
    BACKGROUND OF THE INVENTION
  • Biochemical testing is becoming an increasingly important tool for detecting and monitoring diseases. While tests have long been known for obtaining basic medical information such as blood type and transplant compatibility, for example, advances in understanding the biochemistry underlying many diseases have vastly expanded the number of tests which can be performed. Thus, many tests have become available for various analytical purposes, such as detecting pathogens, diagnosing and monitoring disease, detecting and monitoring changes in health, and monitoring drug therapy.
  • An important obstacle which has limited exploitation of many biochemical tests has been cost. Simultaneous testing of multiple samples for a single analyte has provided some savings. However, simultaneous assays for a large number of analytes within a single sample have been less practical because of the need for extended sample manipulation, multiple test devices, multiple analytical instruments, and other drawbacks.
  • Ideally, a method for analyzing an individual sample using a single test device should provide diagnostic information for a large number of potential analytes while requiring a small amount of sample. The device should be small in size while providing high-sensitivity detection for the analytes of interest. The method should also require minimal sample manipulation. Preferably, the device will include pre-dispensed reagents for specific detection of the analytes.
  • SUMMARY OF THE INVENTION
  • The present invention is directed generally to a method and device for simultaneously testing a sample for the presence, absence, and/or amount of one or more selected analytes.
  • The invention includes, in one aspect, a device for detecting or quantitating one or more of a plurality of different analytes in a liquid sample. The device includes a substrate which defines a sample-distribution network having (i) a sample inlet, (ii) one or more detection chambers, and (iii) channel means providing a dead-end fluid connection between each of the chambers and the inlet. Preferably, each chamber includes an analyte-specific reagent effective to react with a selected analyte that may be present in the sample, and detection means for detecting the signal.
  • In one embodiment, the detection means for each chamber includes an optically transparent window through which the signal can be detected optically. In another embodiment, the detection means includes a non-optical sensor for detecting the signal.
  • The channel means of the device may be configured in numerous ways. For example, in one embodiment, the channel means includes a single channel to which the detection chambers are connected by dead-end fluid connections. In a second embodiment, the channel means includes at least two different channels, each connected to a different group of detection chambers. In yet another embodiment, the channel means includes an individual channel for each detection chamber.
  • The device may include a vacuum port for placing the detection chambers under vacuum prior to the addition of sample. In one embodiment, the vacuum port is connected to the channel means at a site between, and in fluid communication with, the sample inlet and the detection chambers. In another embodiment, the vacuum port is connected to the channel means at a site downstream of the detection chambers. In this configuration, the vacuum port is additionally useful for removing liquid from the channel means after the detection chambers have been filled, to help isolate the detection chambers from one another and further reduce cross-contamination.
  • The vacuum port may be incorporated in a multi-port valve (e.g., a 3-way valve) that permits the network and associated detection chambers to be exposed alternately to a vacuum source, the sample inlet, and a vent or selected gas source.
  • Alternatively, the device of the invention is prepared and sealed under vacuum when manufactured, so that a vacuum port is unnecessary.
  • According to an important feature of the invention, the device is capable of maintaining a vacuum within the sample-distribution network (low internal gas pressure, relative to the external, ambient pressure outside the device) for a time sufficient to allow a sample to be drawn into the network and distributed to the detection chambers by vacuum action. For this purpose, the sample-distribution network may include a vacuum reservoir in fluid communication with, and downstream of, the detection chambers, for preventing the build-up of back-pressure in the network while the detection chambers are successively filled.
  • In one embodiment, the vacuum reservoir includes a non-flowthrough cavity connected downstream of the last-filled detection chamber, for accumulating residual gas displaced from the inlet and channel means. In another embodiment, the reservoir comprises the terminal end of the channel means connected to a vacuum source, allowing residual gas displaced by the sample to be removed continuously until sample loading is complete.
  • The analyte-specific reagents in the detection chambers may be adapted to detect a wide variety of analyte classes, including polynucleotides, polypeptides, polysaccharides, and small molecule analytes, for example. In one embodiment, the analytes are selected-sequence polynucleotides, and the analyte-specific reagents include sequence-selective reagents for detecting the polynucleotides. The polynucleotide analytes are detected by any suitable method, such as polymerase chain reaction, ligase chain reaction, oligonucleotide ligation assay, or hybridization assay.
  • In one particular embodiment, for polynucleotide detection, the analyte-specific reagents include an oligonucleotide primer pair suitable for amplifying, by polymerase chain reaction, a target polynucleotide region in the selected analyte which is flanked by sequences complementary to the primer pair. The presence of target polynucleotide, as indicated by successful amplification, is detected by any suitable means.
  • In another embodiment, the analyte-specific reagents in each detection chamber include an antibody specific for a selected analyte-antigen. In a related embodiment, when the analyte is an antibody, the analyte-specific detection reagents include an antiben for reacting with a selected analyte antibody which may be present in the sample.
  • In yet another embodiment, the device includes means for regulating the temperatures of the detection chambers, preferably providing temperature control between 0 EC and 100 EC, for promoting the reaction of the sample with the detection reagents. In one preferred embodiment, the temperature regulating means includes a conductive heating element for each detection chamber, for rapidly heating the contents of the chamber to a selected temperature. The temperature control means is preferably adapted to regulate the temperatures of the detection chambers, for heating and cooling the chambers in accordance with a selected assay protocol.
  • The device may be manufactured and packaged so that the sample-distribution network (e.g., sample inlet, detection chambers, and channel means) is provided under vacuum, ready for immediate use by the user. Alternatively, the sample-distribution network is provided under atmospheric pressure, so that the evacuation step is carried out by the end-user prior to sample loading.
  • The invention also includes a substrate containing a plurality of sample-distribution networks as described above, for testing a single sample or a plurality of samples for selected analytes.
  • In another aspect, the invention includes a method of making a device such as described above.
  • In another aspect, the invention includes a method for detecting or quantitating a plurality of analytes in a liquid sample. In the method, there is provided a device of the type described above, wherein the interior of the network is placed under vacuum. A liquid sample is then applied to the inlet, and the sample is allowed to be drawn into the sample-distribution network by vacuum action, delivering sample to the detection chambers. The delivered sample is allowed to react with the analyte-specific reagent in each detection chamber under conditions effective to produce a detectable signal when the selected analyte is present in the sample. The reaction chambers are inspected or analyzed to determine the presence and/or amount of the selected analytes in the sample.
  • The device of the invention may also be provided as part of a kit which additionally includes selected reagents, sample preparation materials if appropriate, and instructions for using the device.
  • These and other objects and features of the invention will be more apparent from the following detailed description when read in light with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A and 1B show a plan view (1A) and perspective view (1B) of an exemplary assay device in accordance with the invention;
  • FIGS. 2A-2C illustrate several exemplary sample distribution network configurations in accordance with the invention;
  • FIGS. 3A-3C illustrates a time sequence for the filling of the detection chambers of a sample-distribution network with fluid sample;
  • FIG. 4 illustrates a sample-distribution network containing three sample delivery channels for delivering sample to three different sets of detection chambers;
  • FIG. 5 illustrates a sample-distribution network having a separate delivery channel for each detection chamber;
  • FIGS. 6A-6C illustrate selected features of another sample-distribution network in accordance with the invention; the device is shown in plan view (6A), perspective view (6B), with a portion of the sample distribution network of the device shown in FIG. 6C;
  • FIG. 7 shows an exploded view of a portion of a device in accordance with the invention;
  • FIG. 8 shows an exploded view of a portion of another device in accordance with the invention; and
  • FIG. 9 shows a perspective view of another device in accordance with the invention.
  • DETAILED DESCRIPTION OF THE INVENTION Definitions
  • The following terms and phrases as used herein are intended to have the meanings below.
  • “Dead-end fluid connection between a detection chamber and a sample inlet” refers to a fluid connection which provides the sole fluid access to a detection chamber, such that fluid cannot enter or exit the detection chamber by any other way than through the dead-end fluid connection.
  • In particular, “dead-end fluid connection” refers to a channel whose cross-section is sufficiently narrow to preclude bi-directional fluid flow through the channel. That is, liquid cannot flow through the channel in one direction while air or another liquid is flowing through the channel in the opposite direction.
  • As used herein, “microdevice” means a device in accordance with the invention.
  • Assay Device
  • In one aspect, the present invention provides a device which is useful for testing one or more fluid samples for the presence, absence, and/or amount of one or more selected analytes. The device includes a substrate which defines a sample-distribution network having (i) a sample inlet, (ii) one or more detection chambers (preferably a plurality of detection chambers), and (iii) channel means providing a dead-end fluid connection between each of the chambers and the inlet. Each chamber includes an analyte-specific reagent effective to react with a selected analyte that may be present in such sample.
  • In one embodiment, the substrate also provides, for each chamber, an optically transparent window through which analyte-specific reaction products can be detected. In another embodiment, the detection means for each chamber comprises a non-optical sensor for signal detection.
  • The present invention provides a number of advantages in an assay for multiple analytes in a sample, as will be discussed below. In particular, the invention facilitates the transition from a macro size sample to a micro-sized sample, wherein the device of the invention provides one-step metering of reagents and sample in a multi-analyte detection assay.
  • Network Configurations
  • FIGS. 1A and 1B show a plan view and perspective view, respectively, of an exemplary assay device 30 in accordance with the invention. Device 30 includes a substrate 32 which defines a sample-distribution network 34. With reference to FIG. 1B, the device also includes mount 36 containing a sample inlet 38 and optionally, vacuum port means 40 which is located downstream of the detection chambers.
  • Inlet 38 may be adapted to form a vacuum-tight seal with the end of a syringe, for sample loading, or with a multi-port valve to provide fluid communication with the sample and one or more liquid or gaseous fluids. The inlet may further include a septum cap, if desired, for maintaining the network under vacuum and allowing introduction of sample by canula or needle.
  • Vacuum port 40 may be adapted for connection to a vacuum source, such as a vacuum pump. The vacuum connection may include a valve for closing off the sample-distribution network from the vacuum source, or a multi-port valve for connection to a vacuum source and one or more selected gas supplies.
  • Substrate 30 further provides indentations or holes 42, which may be arranged asymmetrically as illustrated in FIG. 1A, to engage corresponding pins or protrusions in a device-holder, not shown, to immobilize and orient the device for analysis.
  • As noted in the Summary of the Invention, the sample-distribution network of the invention may utilize any of a number of different channel configurations, or channel means, for delivering sample to the individual detection chambers. With reference to FIG. 2A, distribution network 34 a includes sample inlet 38 a, a plurality of detection chambers 44 a, channel means comprising a single channel 46 a to which the detection chambers are each connected by dead-end fluid connections 48 a, and a vacuum port 40 a. The detection chambers are distributed on either side of channel 46 a, with the fluid connections branching off in pairs from opposite sides of the channel. FIG. 2B shows a portion of an alternative network 34 b having an inlet 38 b and detection chambers 44 b, wherein fluid connections 48 b branch off from channel 46 b in a staggered manner.
  • The detection chambers in the device of the invention may be arranged to form a repeating 2-dimensional array which facilitates indexing and identification of the various chambers, as well as allowing rapid measurement of an optical signal produced by each chamber upon reaction with the sample, if optical detection is used.
  • FIGS. 2A-2B, for example, show networks in which the detection chambers are arranged in rows and columns along perpendicular axes, allowing the chambers to be identified by X and Y indices if desired. This type of array (a perpendicular array) also facilitates successive interrogations of the chambers in a chamber-by-chamber analysis mode. However, other arrangements may be used, such as a staggered or a close-packed hexagonal array. FIG. 2C, for example, shows part of a network 34 c having inlet 38 c and an array of staggered detection chambers 44 c. The detection chambers are connected to a common delivery channel 46 c by fluid connections 48 c.
  • The device may also include identifying symbols adjacent the detection chamber to facilitate identification or confirmation of the analytes being detected.
  • Preferably, the detection chambers of the device are each provided with analyte-specific reagents which are effective to react with a selected analyte which may be present in the sample, as discussed further below. Reaction of the sample with the analyte-specific reagents results in production of a detectable signal which indicates that the selected analyte is present.
  • According to an important feature of the invention, the sample is delivered to the detection chambers by vacuum action. Prior to loading with sample, the interior of the sample-distribution network is placed under vacuum so that the residual gas pressure in the network is substantially below atmospheric pressure (i.e., substantially less than 760 mm Hg). One advantage of this feature of the invention is that a pump for pushing fluid through the network is not required. Instead, the device exploits ambient atmospheric pressure to push the sample through the sample inlet and into the sample-distribution network. This allows the sample to be delivered quickly and efficiently to the detection chambers.
  • FIGS. 3A-3C illustrate the filling process for a sample-distribution network 34 in accordance with FIG. 2A. The network includes sample inlet 38, detection chambers 44, and sample delivery channel 46 which is connected to the various detection chambers by dead-end fluid connections 48. The network further includes a vacuum reservoir 40 at the terminus of the delivery channel. A plurality of the detection chambers 44 contain dried detection reagents for detecting a different selected analyte in each chamber, with one or more chambers optionally being reserved as controls.
  • FIG. 3A shows the device before sample loading is initiated. The network is evacuated to establish an internal pressure within the network that is substantially below atmospheric pressure (e.g., 1 to 40 mm Hg). The interior of the network should also be substantially liquid-free to minimize vapor pressure problems. FIG. 3B shows the network after sample fluid 50 has entered the network through inlet 38 (FIG. 3B). As the sample moves through channel 46, the sample sequentially fills each of the detection chambers (FIG. 3B) until all of the chambers have been filled (FIG. 3C). With continued reference to FIG. 3C, once the detection chambers have all been filled, sample fluid may continue to flow through channel 46 into vacuum reservoir 40 until the reservoir becomes full or the flow is otherwise terminated (e.g., by closing a valve associated with the vacuum reservoir).
  • According to one advantage of the invention, continued sample flow through the channel means does not substantially disturb the contents of the detection chambers that have already been filled, because further flow into or out of each filled detection chamber is restricted by the dead-end fluid connections, such as connections 48. Cross-contamination between different detection chambers is therefore reduced, so that erroneous signals due to cross-contamination can be avoided. A further advantage of the invention is that the sample can be mixed with the analyte-specific detection reagents and detected all in the same chamber, without requiring movement of the sample from each chamber to another site. Moreover, since the sample and detection reagents can remain in the chamber for signal detection, the detection reagents need not be immobilized on or adhered to the inner surfaces of the detection chambers.
  • The components of the sample-distribution network are designed to ensure that an adequate volume of sample will be delivered to the detection chambers to allow accurate analyte detection and/or quantitation. In general, the percent-volume of a detection chamber that must be occupied by the sample will vary according to the requirements of the reagents and the detection system used. Typically, the volume-percent will be greater than 75%, preferably greater than 90%, and more preferably greater than 95%. In assay formats in which the detection chambers are heated, particularly to temperatures of between about 60 EC and about 95 EC, the volume-percent filling of the chambers is preferably greater than 95%, and more preferably is at least 99%.
  • The degree to which the detection chambers are filled with sample will generally depend upon (1) the initial ratio of the external (atmospheric) pressure to the initial pressure within the network, (2) the individual and total volumes defined by the detection chambers, (3) the volume defined by the channel means, and (4) the nature of the network downstream of the last detection chamber.
  • For example, in the case of a detection chamber which is nearest the sample inlet, and which will be filled first, the percentage occupancy (volume-percent) of sample fluid in the chamber after sample loading (Vs, %) will be related to the external atmospheric pressure (Pext) and the initial internal pressure within the network before sample loading (Pint) by the expression:

  • Vs, %·(Pext)/(Pext+Pint)
  • Thus, if the initial pressure within the network (Pint) is 10 mm Hg, and the external pressure (Pext) is 760 mm Hg, about 99% of the first detection chamber will be filled with sample fluid (Vs, % 0.99%), with the remaining volume (.1.3%) being filled by residual gas (e.g., air) displaced by the sample. (This calculation assumes that, by the time the sample reaches the chamber, the internal network pressure has not increased appreciably due to displacement of gas upstream of the chamber.) Similarly, if Pext is 760 mm Hg and Pint is only 40 mm Hg, the volume-percent of the chamber that becomes occupied with sample will still be very high (about 95%).
  • It will be appreciated that as the sample fluid reaches and fills successive detection chambers, the residual gas displaced from the channel means will gradually accumulate in the remaining network volume, so that the internal pressure will gradually increase. The resultant increase in back-pressure can lead to a reduction in Vs, % for each successive chamber, with Vs, % for the last-filled detection chamber being significantly lower than the Vs, % for the first-filled chamber.
  • To help avoid this problem, the dimensions of the channel and dead-end fluid connections are preferably selected to define a total volume that is substantially less than the total volume defined by the detection chambers. Preferably, the collective volume of the channel means is less than 20% of the total collective volume of the detection chambers, and more preferably less than 5%. Similarly, the volume of each dead-end fluid connection should be substantially less than the volume of the associated detection chamber. Preferably, the volume of each dead-end connection is less than 20%, preferably less than 10%, and more preferably less than 5% of the volume of the associated detection chamber.
  • The problem of back-pressure can be further diminished by including a vacuum reservoir downstream of the last detection chamber to be filled. In one embodiment, the vacuum reservoir is a non-flowthrough cavity in which gas displaced by the sample fluid can collect. The volume of the reservoir will vary according to the configuration and needs of the particular device. For example, the volume of the reservoir can be selected to be equal in volume to one or more detection chambers volumes, or alternatively, is one-to five-fold as great as the total collective volume of the channel means.
  • In another embodiment, the vacuum reservoir is connected to a vacuum source, so that residual gas can be removed continuously until sample loading into the detection chambers is complete, as discussed further below.
  • FIG. 4 shows another sample-distribution network in accordance with the invention, wherein the channel means of the network includes at least two different sample delivery channels, each connected to a different group of detection chambers. FIG. 4 shows a sample-distribution network 60 having a sample inlet 62, three different groups of detection chambers 64 a, 64 b, and 64 c, and channel means 66 which include corresponding channels 66 a, 66 b, and 66 c associated with the three chamber groups. The chambers are connected to channels 64 a-64 c via dead-end fluid connections 68 a-68 c, which provide uni-directional flow of the sample into the detection chambers.
  • One advantage of using multiple delivery channels is that the time needed to fill the detection chambers with the sample can be significantly reduced relative to the time needed to fill the same number of detection chambers using a single delivery channel. For example, the loading time for a network in accordance with FIG. 4 will be about one-third of that needed to fill an identical number of detection chambers via the single channel format illustrated in FIG. 2A, all other factors being equal. More generally, for a given number of detection chambers, the filling time will vary inversely with the number of delivery channels used.
  • The sample-distribution network in FIG. 4 further includes separate vacuum reservoirs 70 a-70 c which are connected to the termini of sample delivery channels 64 a-64 c, downstream of the detection chambers. The vacuum chambers are dimensioned to help maintain a low internal gas pressure during sample loading.
  • In another embodiment, the channel means includes an individual channel for each detection chamber, as illustrated in FIG. 5. Network 80 includes an inlet 82, detection chambers 84, and associated with each detection chamber, a dead-end fluid connection 86, which may also be referred to as channel means, for delivering sample to each chamber. Each dead-end fluid connection is dimensioned to define a volume that is substantially less than the volume of the associated detection chamber, to ensure that each detection chamber is sufficiently filled with sample. This embodiment provides rapid filling of the detection chambers with minimal cross-contamination.
  • The device of the invention may also include a vacuum port communicating with the sample-distribution network, for applying a vacuum to the network before or during sample loading. In one embodiment, the vacuum port is connected to the channel means at a site between, and in fluid communication with, the sample inlet and the detection chambers. An illustration of this can be found in FIG. 9. The vacuum port thus provides a convenient way to reduce the internal pressure within the network to a selected residual pressure prior to sample loading. In particular, when the sample is introduced into the network using a syringe barrel connected to the sample inlet, the vacuum port can be used to remove air from the space between the syringe and the inlet, before the sample is admitted into the network.
  • In another embodiment, the vacuum port is connected to the channel means at a site downstream of the sample inlet and detection chambers (e.g., FIG. 6A). In this configuration, the vacuum port may additionally be used to remove liquid from the channel means after the detection chambers have been filled, to help isolate the detection chambers from one another and further reduce cross-contamination. In this configuration, the vacuum port constitutes a part of the vacuum reservoir described above, where the reservoir includes a vacuum source linked to the terminal end of a sample delivery channel. The vacuum port may be kept open to the network during sample loading, to continuously remove residual gas from the network until all of the detection chambers have been filled.
  • The vacuum port may include a multi-port valve (e.g., 3-way valve) that permits the network and associated detection chambers to be exposed alternately to a vacuum source, the sample inlet, and a vent or gas source. Such a valve may be used to alternately expose the network to vacuum and a selected gas source, to replace residual air with the selected gas. Such gas replacement in the network may be useful to remove molecular oxygen (O2) or other atmospheric gases which might otherwise interfere with the performance of the detection reagents.
  • Argon and nitrogen are inert gases which may be suitable for most situations. Another gas which may be used is carbon dioxide (CO2), which is highly soluble in water due to its ability to form carbonate and bicarbonate ions. When the sample fluid is an aqueous solution, bubbles of carbon dioxide which may form in the network during sample loading may be eliminated via dissolution in the sample fluid. The degree of sample filling in the detection chambers is therefore enhanced. Of course, carbon dioxide should not be used if it interferes with the detection reagents.
  • A multi-port valve such as noted above can also be used to supply a gas which is required for detection of the selected analytes. For example, it may be desirable to provide molecular oxygen or ozone where the detection reagents involve an oxidation reaction. Other gases, such as hydrocarbons (ethylene, methane) or nitrogenous gases, may also be introduced as appropriate.
  • Device Fabrication
  • The device of the invention is designed to allow testing of a sample for a large number of different analytes by optical analysis, using a device that is compact and inexpensive to prepare. Generally, the device will be no larger in cross-section than the cross-section of a standard credit card (≦5 cm×10 cm), and will have a thickness (depth) of no greater than 2 cm. More preferably, the device occupies a volume of no greater than about 5×5×1 cm, excluding attachments for the sample inlet and any vacuum port. More preferably, the device has dimensions of no greater than about 3 cm×2 cm×0.3 cm. Devices smaller than this are also contemplated, bearing in mind that the device should provide adequate sensitivity and be easy for the end-user to handle.
  • The detection chambers in the device are generally designed to be as small as possible, in order to achieve high density of detection chambers. The sizes and dimensions of the chambers will depend on a number of considerations. When signal detection is by optical means, the overhead cross-section of each chamber must be large enough to allow reliable measurement of the signal produced when the selected analyte is present in the sample. Also, the depths of the chambers can be tailored for the particular optical method used. For fluorescence detection, thin chambers may be desirable, to minimize quenching effects. For absorbance or chemiluminescence detection, on the other hand, a thicker chamber may be appropriate, to increase the detection signal.
  • It will be appreciated that while the figures in the attached drawings show chambers having square-shaped overhead cross-sections, other geometries, such as circles or ovals, may also be used. Similarly, the channels in the network may be straight or curved, as necessary, with cross-sections that are shallow, deep, square, rectangular, concave, or V-shaped, or any other appropriate configuration.
  • Typically, the detection chambers will be dimensioned to hold from 0.001 μL to 10 μL of sample per chamber, and, more preferably between 0.01 μL and 2 μL. Conveniently, the volume of each detection chamber is between about 0.1 μL and 1 μL, to allow visual confirmation that the chambers have been filled. For example, a chamber having a volume of 0.2 μL may have dimensions of 1 mm×1 mm×0.2 mm, where the last dimension is the chamber's depth.
  • The sample delivery channels are dimensioned to facilitate rapid delivery of sample to the detection chambers, while occupying as little volume as possible. Typical cross-sectional dimensions for the channels will range from 5 μm to about 250 μm for both the width and depth. Ideally, the path lengths between chambers will be as short as possible to minimize the total channel volume. For this purpose (to minimize volume), the network is preferably substantially planar, i.e., the channel means and detection chambers in the device intersect a common plane.
  • The substrate that defines the sample-distribution network of the invention may be formed from any solid material that is suitable for conducting analyte detection. Materials which may be used will include various plastic polymers and copolymers, such as polypropylenes, polystyrenes, polyimides, and polycarbonates. Inorganic materials such as glass and silicon are also useful. Silicon is especially advantageous in view of its high thermal conductivity, which facilitates rapid heating and cooling of the device if necessary. The substrate may be formed from a single material or from a plurality of materials.
  • The sample-distribution network is formed by any suitable method known in the art. For plastic materials, injection molding will generally be suitable to form detection chambers and connecting channels having a desired pattern. For silicon, standard etching techniques from the semiconductor industry may be used, as described in Sze (1988), for example.
  • Typically, the device substrate is prepared from two or more laminated layers, as will be discussed below with reference to FIGS. 6A-6C to 8. For optical detection, the device will include one or more layers which provide an optically transparent window for each detection chamber, through which the analyte-specific signal is detected. For this purpose, silica-based glasses, quartz, polycarbonate, or an optically transparent plastic layer may be used, for example. Selection of the particular window material depends in part on the optical properties of the material. For example, in a fluorescence-based assay, the material should have low fluorescence emission at the wavelength(s) being measured. The window material should also exhibit minimal light absorption for the signal wavelengths of interest.
  • Other layers in the device may be formed using the same or different materials. Preferably, the layer or layers defining the detection chambers are formed predominantly from a material that has high heat conductivity, such as silicon or a heat-conducting metal. The silicon surfaces which contact the sample are preferably coated with an oxidation layer or other suitable coating, to render the surface more inert. Similarly, where a heat-conducting metal is used in the substrate, the metal can be coated with an inert material, such as a plastic polymer, to prevent corrosion of the metal and to separate the metal surface from contact with the sample. The suitability of a particular surface should be verified for the selected assay.
  • For optical detection, the opacity or transparency of the substrate material defining the detection chambers will generally have an effect on the permissible detector geometries used for signal detection. For the following discussion, references to the “upper wall” of a detection chamber refer to the chamber surface or wall through which the optical signal is detected, and references to the “lower wall” of a chamber refers to the chamber surface or wall that is opposite the upper wall.
  • When the substrate material defining the lower wall and sides of the detection chambers is optically opaque, and detection is by absorption or fluorescence, the detection chambers will usually be illuminated and optically scanned through the same surface (i.e., the top surfaces of the chambers which are optically transparent). Thus, for fluorescence detection, the opaque substrate material preferably exhibits low reflectance properties so that reflection of the illuminating light back toward the detector is minimized. Conversely, a high reflectance will be desirable for detection based on light absorption.
  • When the substrate material defining the upper surface and sides of the detection chambers is optically clear, and detection involves fluorescence measurement, the chambers can be illuminated with excitation light through the sides of the chambers (in the plane defined collectively by the detection chambers in the device), or more typically, diagonally from above (e.g., at a 45 degree angle), and emitted light is collected from above the chambers (i.e., through the upper walls, in a direction perpendicular to the plane defined by the detection chambers). Preferably, the substrate material exhibits low dispersion of the illuminating light in order to limit Rayleigh scattering.
  • When the entirety of the substrate material is optically clear, or at least the upper and lower walls of the chambers are optically clear, the chambers can be illuminated through either wall (upper or lower), and the emitted or transmitted light is measured through either wall as appropriate. Illumination of the chambers from other directions will also be possible as already discussed above.
  • With chemiluminescence detection, where light of a distinctive wavelength is typically generated without illumination of the sample by an outside light source, the absorptive and reflective properties of the substrate will be less important, provided that the substrate provides at least one optically transparent window for detecting the signal.
  • FIGS. 6A-6C illustrate a specific embodiment of a device in accordance with the invention. With reference to FIGS. 6A and 6B, device 100 includes a sample inlet 102, sample-distribution network 104, and vacuum port 106 which is connected to the terminus of network 104. Network 104 includes a perpendicular array of detection chambers 108 (7 rows×8 columns) linked to sample delivery channel 110 via dead-end fluid connections 112. The device further includes vertical panel 114 adjacent sample inlet 102, for attaching an identifying label to the device and as an attachment allowing the user to hold the device.
  • As can be seen from FIG. 6B, the detection chambers are packed closely together to increase the number of analytes which can be tested in the device. Fluid connections 112 are provided in an L-shaped configuration (FIG. 6C) to impede fluid flow out of the chambers after sample loading, and to help isolate the contents of the chambers from each other. Although the horizontal rows of detection chambers in FIGS. 6A and 6B are shown as being separated from each other by variable vertical spacing (to enhance the clarity of the figures), it will be appreciated that the chambers can be separated by equal distances in both the vertical and ho
  • FIGS. 7 and 8 illustrate two exemplary approaches for forming a testing device in accordance with FIGS. 6A-6B. FIG. 7 shows two substrate layers 140 and 142 which can be brought together to form sample-distribution network 104 (FIG. 6A). The network is defined primarily by substrate layer 140, which contains indentations defining a sample inlet 102 (not shown), a plurality of detection chambers 108, sample delivery channel 110, and dead-end fluid connections 112. Contact of substrate layer 142 with the opposing face of layer 140 completes the formation of network 104.
  • FIG. 8 shows substrate layers 150 and 152 for forming a network by another approach. Substrate layer 150 contains indentations defining a plurality of detection chambers 108. Substrate layer 152, on the other hand, contains indentations defining sample delivery channel 110 and dead-end fluid connections 112. Network 104 can then be formed by contacting the opposing faces of the two substrate layers as in FIG. 7.
  • Since the device is designed to provide a vacuum-tight environment within the sample-distribution network for sample loading, and also to provide detection chambers having carefully defined reaction volumes, it is desirable to ensure that the network and associate detection chambers do not leak. Accordingly, lamination of substrate layers to one another should be accomplished so as to ensure that all chambers and channels are well sealed.
  • In general, the substrate layers can be sealably bonded in a number of ways. Conventionally, a suitable bonding substance, such as a glue or epoxy-type resin, is applied to one or both opposing surfaces that will be bonded together. The bonding substance may be applied to the entirety of either surface, so that the bonding substance (after curing) will come into contact with the detection chambers and the distribution network. In this case, the bonding substance is selected to be compatible with the sample and detection reagents used in the assay. Alternatively, the bonding substance may be applied around the distribution network and detection chambers so that contact with the sample will be minimal or avoided entirely. The bonding substance may also be provided as part of an adhesive-backed tape or membrane which is then brought into contact with the opposing surface. In yet another approach, the sealable bonding is accomplished using an adhesive gasket layer which is placed between the two substrate layers. In any of these approaches, bonding may be accomplished by any suitable method, including pressure-sealing, ultrasonic welding, and heat curing, for example.
  • The device of the invention may be adapted to allow rapid heating and cooling of the detection chambers to facilitate reaction of the sample with the analyte-detection reagents. In one embodiment, the device is heated or cooled using an external temperature-controller. The temperature-controller is adapted to heat/cool one or more surfaces of the device, or may be adapted to selectively heat the detection chambers themselves.
  • To facilitate heating or cooling with this embodiment, the substrate material of the test device is preferably formed of a material which has high thermal conductivity, such as copper, aluminum, or silicon. Alternatively, a substrate layer such as layer 140 in FIG. 7 may be formed from a material having moderate or low thermal conductivity, while substrate layer 142 (FIG. 7) is provided as a thin layer, such that the temperature of the detection chambers can be conveniently controlled by heating or cooling the device through layer 142, regardless of the thermal conductivity of the material of layer 142. In one preferred embodiment, layer 142 is provided in the form of an adhesive copper-backed tape.
  • In an alternative embodiment, means for modulating the temperature of the detection chambers is provided in the substrate of the device itself. For example, with reference to FIG. 7, substrate layer 142 may include resistive traces which contact regions adjacent the reaction chambers, whereby passage of electrical current through the traces is effective to heat or cool the chambers. This approach is particularly suitable for silicon-based substrates, and can provide superior temperature control.
  • Further illustration of the invention is provided by the device shown in FIG. 9. Device 160 includes a network-defining substrate layer 161 and a flat substrate layer 180 for bonding with and sealing layer 161.
  • Layer 161 includes sample inlet 162 and indentations defining (i) a sample-distribution network 164 and (ii) vacuum reservoir 166 connected to the terminus of network 164. Network 164 includes a 2-dimensional perpendicular array of detection chambers 168 (7×7) linked to sample delivery channel 170 via dead-end fluid connections 172. The device further includes vertical panel 174 adjacent sample inlet 162, as in FIGS. 6A-6B. Formation of network 164 is completed by contacting the entirety of the upper surface of device 160 with the opposing face of a layer 180, which is preferably provided in the form of a membrane or thin layer.
  • Device 160 in FIG. 9 is distinguished from device 100 in FIG. 6A in that device 160 includes a vacuum reservoir 166, instead of a vacuum port, at the terminus of delivery channel 170. In addition, sample inlet 162 in device 160 is conveniently adapted to operate in conjunction with inlet fitting 190, so that evacuation of the network and sample loading can be effected from a single site with respect to the network.
  • Sample inlet 162 includes a hollow inlet cylinder 176 having an open proximal end 177, which connects to network 164, and an open, distal end 178. Cylinder 176 further includes an opening 179 located near the terminus of the distal end.
  • Inlet fitting 190 includes an inlet cap structure 200 and a port structure 210 appended thereto. Cap structure 200 defines a hollow cylinder 202 having an open, proximal end 204 and a closed, distal end 206. The inner diameter of cylinder 202 is dimensioned to form a vacuum-tight seal when placed over inlet 162. Port structure 210 defines a vacuum port 212 and a sample port 214. Ports 212 and 214 communicate with cylinder 202 via openings 216 and 218, respectively, which are formed in the side of cylinder 202. Fitting 190 additionally includes guide structure 220 for receiving the adjacent edge of panel 174, to orient and guide fitting 190 when fitting 190 is fitted over and slided along inlet 162.
  • Exemplary dimensions of a device which has been prepared in accordance with FIG. 9 are the following: detection chambers 168, 1.2 mm×1.2 mm×0.75 mm; delivery channel 170, 0.25 mm×0.25 mm (width×depth); dead-end fluid connection 172, 0.25 mm×0.25 mm (width×depth); external dimensions: 22 cm×15 cm×1 mm (dimensions of network-defining portion, excluding inlet 162 and panel 174). Preferably, the detection chambers in the microdevice of the invention have volumes less than 10 μL, less than 2 μL, and most preferably less than or equal to 1 μL.
  • Device 160 may be prepared under ordinary atmospheric conditions by bonding a polymeric, adhesive-backed substrate layer 180 to the corresponding surface of layer 161, to form a sealed network. Inlet fitting 190 is fitted onto cylinder 176 of inlet 162, such that openings 179 and 216 are aligned with each other. Vacuum port 212 is connected to a vacuum line, and the interior of the network is evacuated for a selected time. The network may be alternately flushed with a selected gas, such as carbon dioxide, and vacuum, as discussed above. During evacuation, sample port 214 is loaded with, or placed in fluid communication with, the fluid sample. Preferably, the sample port is filled so that there is no air between the sample in the sample port and opening 218. Once the network has been evacuated (usually complete within a few seconds), fitting 190 is lowered further towards layer 161 until opening 179 is aligned with sample opening 218, bringing the interior of the network in fluid communication with the sample. The sample fills the chambers rapidly, typically in less than half a second. The detection chambers are filled to a volume-percent of greater than 95%. Excess sample and residual gas collects in reservoir 166.
  • Once the chambers have filled with sample, fitting 190 is lowered further toward layer 161 in order to seal inlet 162, thereby sealing the interior of the network from the outside atmosphere. The sample is allowed to react with the detection reagents in the detection chambers, during or after which the optical signals produced in the chambers are detected.
  • Detection Reagents
  • The detection chamber(s) of the device may be pre-loaded with detection reagents which are specific for the selected analytes of interest. The detection reagents are designed to produce an optically detectable signal via any of the optical methods noted in Section II below.
  • It will be appreciated that although the reagents in each detection chamber must contain substances specific for the analyte(s) to be detected in the particular chamber, other reagents necessary to produce the optical signal for detection may be added to the sample prior to loading, or may be placed at locations elsewhere in the network for mixing with the sample. Whether particular assay components are included in the detection chambers or elsewhere will depend on the nature of the particular assay, and on whether a given component is stable to drying. In general, it is preferred that as many of the detection reagents as possible are pre-loaded in the detection chambers during manufacture of the device, in order to enhance assay uniformity and minimize the assay steps conducted by the end-user.
  • The analyte to be detected may be any substance whose presence, absence, or amount is desirable to be determined. The detection means can include any reagent or combination of reagents suitable to detect or measure the analyte(s) of interest. It will be appreciated that more than one analyte can be tested for in a single detection chamber, if desired.
  • In one embodiment, the analytes are selected-sequence polynucleotides, such as DNA or RNA, and the analyte-specific reagents include sequence-selective reagents for detecting the polynucleotides. The sequence-selective reagents include at least one binding polymer which is effective to selectively bind to a target polynucleotide having a defined sequence.
  • The binding polymer can be a conventional polynucleotide, such as DNA or RNA, or any suitable analog thereof which has the requisite sequence selectivity. For example, binding polymers which are analogs of polynucleotides, such as deoxynucleotides with thiophosphodiester linkages, and which are capable of base-specific binding to single-stranded or double-stranded target polynucleotides may be used. Polynucleotide analogs containing uncharged, but stereoisomeric methylphosphonate linkages between the deoxyribonucleoside subunits have been reported (Miller, 1979, 1980, 1990, Murakami, Blake, 1985a, 1985b). A variety of analogous uncharged phosphoramidate-linked oligonucleotide analogs have also been reported (Froehler). Also, deoxyribonucleoside analogs having achiral and uncharged intersubunit linkages (Stirchak) and uncharged morpholino-based polymers having achiral intersubunit linkages have been reported (U.S. Pat. No. 5,034,506). Binding polymers known generally as peptide nucleic acids may also be used (Buchardt, 1992). The binding polymers may be designed for sequence specific binding to a single-stranded target molecule through Watson-Crick base pairing, or sequence-specific binding to a double-stranded target polynucleotide through Hoogstein binding sites in the major groove of duplex nucleic acid (Kornberg). A variety of other suitable polynucleotide analogs are also known.
  • The binding polymers for detecting polynucleotides are typically 10-30 nucleotides in length, with the exact length depending on the requirements of the assay, although longer or shorter lengths are also contemplated.
  • In one embodiment, the analyte-specific reagents include an oligonucleotide primer pair suitable for amplifying, by polymerase chain reaction, a target polynucleotide region of the selected analyte which is flanked by 3′-sequences complementary to the primer pair. In practicing this embodiment, the primer pair is reacted with the target polynucleotide under hybridization conditions which favor annealing of the primers to complementary regions of opposite strands in the target. The reaction mixture is then thermal cycled through several, and typically about 20-40, rounds of primer extension, denaturation, and primer/target sequence annealing, according to well-known polymerase chain reaction (PCR) methods (Mullis, Saiki).
  • Typically, both primers for each primer pair are pre-loaded in each of the respective detection chambers, along with the standard nucleotide triphosphates, or analogs thereof, for primer extension (e.g., ATP, CTP, GTP, and TTP), and any other appropriate reagents, such as MgCl2 or MnCl2. A thermally stable DNA polymerase, such as Taq, Vent, or the like, may also be pre-loaded in the chambers, or may be mixed with the sample prior to sample loading. Other reagents may be included in the detection chambers or elsewhere as appropriate. Alternatively, the detection chambers may be loaded with one primer from each primer pair, and the other primer (e.g., a primer common to all of detection chambers) may be provided in the sample or elsewhere.
  • If the target polynucleotides are single-stranded, such as single-stranded DNA or RNA, the sample is preferably pre-treated with a DNA- or RNA-polymerase prior to sample loading, to form double-stranded polynucleotides for subsequent amplification.
  • The presence and/or amount of target polynucleotide in a detection chamber, as indicated by successful amplification, is detected by any suitable means. For example, amplified sequences may be detected in double-stranded form by including an intercalating or cross-linking dye, such as ethidium bromide, acridine orange, or an oxazole derivative, for example, which exhibits a fluorescence increase or decrease upon binding to double-stranded nucleic acids (Sambrook, 1989; Ausubel; Higuchi, 1992, 1993; Ishiguro, 1995).
  • The level of amplification can also be measured by fluorescence detection using a fluorescently labeled oligonucleotide, such as disclosed in Lee et al. (1993) and Livak et al. (1995). In this embodiment, the detection reagents include a sequence-selective primer pair as in the more general PCR method above, and in addition, a sequence-selective oligonucleotide (FQ-oligo) containing a fluorescer-quencher pair. The primers in the primer pair are complementary to 3′-regions in opposing strands of the target analyte segment which flank the region which is to be amplified. The FQ-oligo is selected to be capable of hybridizing selectively to the analyte segment in a region downstream of one of the primers and is located within the region to be amplified.
  • The fluorescer-quencher pair includes a fluorescer dye and a quencher dye which are spaced from each other on the oligonucleotide so that the quencher dye is able to significantly quench light emitted by the fluorescer at a selected wavelength, while the quencher and fluorescer are both bound to the oligonucleotide. The FQ-oligo preferably includes a 3′-phosphate or other blocking group to prevent terminal extension of the 3′-end of the oligo.
  • The fluorescer and quencher dyes may be selected from any dye combination having the proper overlap of emission (for the fluorescer) and absorptive (for the quencher) wavelengths while also permitting enzymatic cleavage of the FQ-oligo by the polymerase when the oligo is hybridized to the target. Suitable dyes, such as rhodamine and fluorscein derivatives, and methods of attaching them, are well known and are described, for example, in Menchen et al. (1993, 1994), Bergot et al. (1991), and Fung et al. (1987).
  • The fluorescer and quencher dyes are spaced close enough together to ensure adequate quenching of the fluorescer, while also being far enough apart to ensure that the polymerase is able to cleave the FQ-oligo at a site between the fluorescer and quencher. Generally, spacing of about 5 to about 30 bases is suitable, as generally described in Livak et al. (1995). Preferably, the fluorescer in the FQ-oligo is covalently linked to a nucleotide base which is 5′ with respect to the quencher.
  • In practicing this approach, the primer pair and FQ-oligo are reacted with a target polynucleotide (double-stranded for this example) under conditions effective to allow sequence-selective hybridization to the appropriate complementary regions in the target. The primers are effective to initiate extension of the primers via DNA polymerase activity. When the polymerase encounters the FQ-probe downstream of the corresponding primer, the polymerase cleaves the FQ-probe so that the fluorescer is no longer held in proximity to the quencher. The fluorescence signal from the released fluorescer therefore increases, indicating that the target sequence is present.
  • One advantage of this embodiment is that only a small proportion of the FQ-probe need be cleaved in order for a measurable signal to be produced. In a further embodiment, the detection reagents may include two or more FQ-oligos having distinguishable fluorescer dyes attached, and which are complementary for different-sequence regions which may be present in the amplified region, e.g., due to heterozygosity (Lee, 1993).
  • In another embodiment, the detection reagents include first and second oligonucleotides effective to bind selectively to adjacent, contiguous regions of a target sequence in the selected analyte, and which may be ligated covalently by a ligase enzyme or by chemical means (Whiteley, 1989; Landegren, 1988) (oligonucleotide ligation assay, OLA). In this approach, the two oligonucleotides (oligos) are reacted with the target polynucleotide under conditions effective to ensure specific hybridization of the oligo-nucleotides to their target sequences. When the oligonucleotides have base-paired with their target sequences, such that confronting end subunits in the oligos are basepaired with immediately contiguous bases in the target, the two oligos can be joined by ligation, e.g., by treatment with ligase. After the ligation step, the detection wells are heated to dissociate unligated probes, and the presence of ligated, target-bound probe is detected by reaction with an intercalating dye or by other means.
  • The oligos for OLA may also be designed so as to bring together a fluorescer-quencher pair, as discussed above, leading to a decrease in a fluorescence signal when the analyte sequence is present.
  • In the above OLA ligation method, the concentration of a target region from an analyte polynucleotide can be increased, if necessary, by amplification with repeated hybridization and ligation steps. Simple additive amplification can be achieved using the analyte polynucleotide as a target and repeating denaturation, annealing, and ligation steps until a desired concentration of the ligated product is achieved.
  • Alternatively, the ligated product formed by hybridization and ligation can be amplified by ligase chain reaction (LCR), according to published methods (Winn-Deen). In this approach, two sets of sequence-specific oligos are employed for each target region of a double-stranded nucleic acid. One probe set includes first and second oligonucleotides designed for sequence-specific binding to adjacent, contiguous regions of a target sequence in a first strand in the target. The second pair of oligonucleotides are effective to bind (hybridize) to adjacent, contiguous regions of the target sequence on the opposite strand in the target. With continued cycles of denaturation, reannealing and ligation in the presence of the two complementary oligo sets, the target sequence is amplified exponentially, allowing small amounts of target to be detected and/or amplified.
  • In a further modification, the oligos for OLA or LCR assay bind to adjacent regions in a target polynucleotide which are separated by one or more intervening bases, and ligation is effected by reaction with (i) a DNA polymerase, to fill in the intervening single stranded region with complementary nucleotides, and (ii) a ligase enzyme to covalently link the resultant bound oligonucleotides (Segev, 1992, 1994).
  • In another embodiment, the target sequences can be detected on the basis of a hybridization-fluorescence assay (Lee et al., 1993). The detection reagents include a sequence-selective binding polymer (FQ-oligo) containing a fluorescer-quencher pair, as discussed above, in which the fluorescence emission of the fluorescer dye is substantially quenched by the quencher when the FQ-oligo is free in solution (i.e., not hybridized to a complementary sequence).
  • Hybridization of the FQ-oligo to a complementary sequence in the target to form a double-stranded complex is effective to perturb (e.g., increase) the fluorescence signal of the fluorescer, indicating that the target is present in the sample. In another embodiment, the binding polymer contains only a fluorescer dye (but not a quencher dye) whose fluorescence signal either decreases or increases upon hybridization to the target, to produce a detectable signal.
  • It will be appreciated that since the selected analytes in the sample will usually be tested for under generally uniform temperature and pressure conditions within the device, the detection reagents in the various detection chambers should have substantially the same reaction kinetics. This can generally be accomplished using oligonucleotides and primers having similar or identical melting curves, which can be determined by empirical or experimental methods as are known in the art.
  • In another embodiment, the analyte is an antigen, and the analyte-specific reagents in each detection chamber include an antibody specific for a selected analyte-antigen. Detection may be by fluorescence detection, agglutination, or other homogeneous assay format. As used herein, “antibody” is intended to refer to a monoclonal or polyclonal antibody, an Fc portion of an antibody, or any other kind of binding partner having an equivalent function.
  • For fluorescence detection, the antibody may be labeled with a fluorescer compound such that specific binding of the antibody to the analyte is effective to produce a detectable increase or decrease in the compound's fluorescence, to produce a detectable signal (non-competitive format). In an alternative embodiment (competitive format), the detection means includes (i) an unlabeled, analyte-specific antibody, and (ii) a fluorescer-labeled ligand which is effective to compete with the analyte for specifically binding to the antibody. Binding of the ligand to the antibody is effective to increase or decrease the fluorescence signal of the attached fluorescer. Accordingly, the measured signal will depend on the amount of ligand that is displaced by analyte from the sample. Exemplary fluorescence assay formats which may be adapted for the present invention can be found in Ullman (1979, 1981) and Yoshida (1980), for example.
  • In a related embodiment, when the analyte is an antibody, the analyte-specific detection reagents include an antigen for reacting with a selected analyte antibody which may be present in the sample. The reagents may be adapted for a competitive or non-competitive type format, analogous to the formats discussed above. Alternatively, the analyte-specific reagents include a mono- or polyvalent antigen having one or more copies of an epitope which is specifically bound by the antibody-analyte, to promote an agglutination reaction which provides the detection signal.
  • In yet another embodiment, the selected analytes are enzymes, and the detection reagents include enzyme-substrate molecules which are designed to react with specific analyte enzymes in the sample, based on the substrate specificities of the enzymes. Accordingly, detection chambers in the device each contain a different substrate or substrate combination, for which the analyte enzyme(s) may be specific. This embodiment is useful for detecting or measuring one or more enzymes which may be present in the sample, or for probing the substrate specificity of a selected enzyme. Particularly preferred detection reagents include chromogenic substrates such as NAD/NADH, FAD/FADH, and various other reducing dyes, for example, useful for assaying hydrogenases, oxidases, and enzymes that generate products which can be assayed by hydrogenases and oxidases. For esterase or hydrolase (e.g., glycosidase) detection, chromogenic moieties such as nitrophenol may be used, for example.
  • In another embodiment, the analytes are drug candidates, and the detection reagents include a suitable drug target or an equivalent thereof, to test for binding of the drug candidate to the target. It will be appreciated that this concept can be generalized to encompass screening for substances that interact with or bind to one or more selected target substances. For example, the assay device can be used to test for agonists or antagonists of a selected receptor protein, such as the acetylcholine receptor. In a further embodiment, the assay device can be used to screen for substrates, activators, or inhibitors of one or more selected enzymes. The assay may also be adapted to measure dose-response curves for analytes binding to selected targets.
  • The sample or detection reagents may also include a carrier protein, such as bovine serum albumin (BSA) to reduce non-specific binding of assay components to the walls of the detection chambers.
  • The analyte-specific detection reagents are preferably dispensed into the detection chambers robotically using a dispensing system designed to deliver small volumes of liquid solutions (e.g., 0.1 to 1 μL). The system is supplied with separate analyte-specific detection reagents which are dispensed to pre-selected detection chambers without cross-contamination.
  • A reagent loading device that has been prepared in accordance with the invention includes a dispensing robot (Asymtek Automove 402) coupled to a plurality of drop-on-demand ink-jet printing heads. The robot includes an X,Y-axis work table (12 inch×12 inch) having a lateral resolution of 0.001 inch, a lateral velocity of 0-20 inch/sec, a Z-axis resolution of 0.001 inch, and a Z-axis velocity of 0-8 inch/sec. The robot optionally includes a tip locator, offset camera, strobe drop camera, on-axis camera, and/or gravimetric drop calibration. The printing heads are of a drop-on-demand, piezo-electric type, having wetted surfaces usually selected from glass, Teflon?, and polypropylene. The minimum drop volume is 25 nL, and the maximum flow is 1 μL/min.
  • Reagent loading is preferably accomplished under carefully-controlled sterile conditions using one or more dedicated dispensing robots. After application, the reagents are allowed to dry in the chambers until most or all of the solvent has evaporated. Drying may be accelerated by baking or reduced pressure as appropriate. The detection chambers are then sealed by bonding the chamber containing substrate layer with an appropriate cover layer, and the device is ready for use.
  • Signal Detection and Analysis
  • The signal produced by reaction of the analyte-specific reagents with the sample is measured by any suitable detection means, including optical and non-optical methods.
  • Where the signal is detected optically, detection may be accomplished using any optical detector that is compatible with the spectroscopic properties of the signal. The assay may involve an increase in an optical signal or a decrease. The optical signal may be based on any of a variety of optical principals, including fluorescence, chemiluminescence, light absorbance, circular dichroism, optical rotation, Raman scattering, radioactivity, and light scattering. Preferably, the optical signal is based on fluorescence, chemiluminescence, or light absorbance.
  • In general, the optical signal to be detected will involve absorbance or emission of light having a wavelength between about 180 nm (ultraviolet) and about 50 μm (far infrared). More typically, the wavelength is between about 200 nm (ultraviolet) and about 800 nm (near infrared). A variety of detection apparatus for measuring light having such wavelengths are well known in the art, and will typically involve the use of light filters, photomultipliers, diode-based detectors, and/or charge-coupled detectors (CCD), for example.
  • The optical signals produced in the individual detection chambers may be measured sequentially by iteratively scanning the chambers one at a time or in small groups, or may be measured simultaneously using a detector which interrogates all of the detection chambers continuously or at short time intervals. Preferably, the signals are recorded with the aid of a computer capable of displaying instantaneously (in real-time) the signal level in each of the detection chambers, and also storing the time courses of the signals for later analysis.
  • The optical signal in each chamber may be based on detection of light having one or more selected wavelengths with defined band-widths (e.g., 500 nm±5 nm). Alternatively, the optical signal may be based on the shape or profile of emitted or absorbed light in a selected wavelength range. Preferably, the optical signal will involve measurement of light having at least two distinctive wavelengths in order to include an internal control. For example, a first wavelength is used to measure the analyte, and a second wavelength is used to verify that the chamber is not empty or to verify that a selected reagent or calibration standard is present in the detection chamber. An aberration or absence of the signal for the second wavelength is an indication that the chamber may be empty, that the sample was improperly prepared, or that the detection reagents are defective.
  • In studies conducted in support of the invention, a detection assembly was prepared for fluorescence detection of target polynucleotides in a sample using a device in accordance with the invention. The assembly includes a translation stage for positioning the test device. The test device includes a 7×7 array of addressable detection chambers containing fluorescent detection reagents. The detector in the assembly consists of a tungsten bulb (or quartz halogen bulb, 75 W) illumination source, a CCD camera, and appropriate focusing/collection optics. The illumination source is positioned so as to illuminate the device diagonally from above (e.g., at an inclination angle of 45 degrees with respect to the illuminated surface). The optics include two lenses separated by an emission filter. The first lens collimates the incoming image for the emission filter, and the second lens which re-images the filtered beam onto the CCD. The test device is placed at the focal point of the first lens.
  • The CCD is a thermoelectrically cooled, instrumentation-grade front-illuminated CCD (Princeton Instruments TEA/CCD-512TK/1). The detection plate of the CCD has a 512×512 array of 27 μm square pixels which covers the entire overhead cross-section of the test device. The camera head is controlled by a controller (Princeton Instruments ST-135) which communicates with a computer (Quadra 650, Apple Computers) for collecting and processing the signal data. The system is capable of on-chip binning of the pixels. For detection chambers having an overhead cross-section of 1 mm×1 mm, bins having a size of 2×2 pixels are suitable. More generally, the bin size is selected on the basis of the total processing time that will be required, the sizes and number of detection chambers, sensitivity, and signal noise.
  • The computer in the assembly includes signal-processing software for selecting an appropriate sub-region in each detection chamber from which the signal is measured. Such sub-regions are selected for uniformity of incoming light, to ensure that edge regions are excluded. The signal image of the device is recorded and stored at selected intervals, according to the requirements of the assay. Preferably, the signal for each detection chamber is recorded as an average signal per bin for the selected sub-region in each chamber, since the size of the selected sub-region in each chamber will usually differ from chamber to chamber.
  • The detector optics may further be adapted to include a filter wheel for detecting fluorescence at 2 or more wavelengths.
  • As discussed above, the temperature of the detection chambers may be controlled, if appropriate, by any of a number of suitable methods. In the detection assembly that was prepared in accordance with the invention, the heating means is external to the test device (off-chip heating), and includes a temperature controller (Marlow Industries model SE 5020) equipped with a peltier device (ITI Ferro Tec model 6300) having a ramp rate of about ±4 E/sec in the range of 55 EC to 95 EC. For on-chip heating, where the device includes resistive tracings (or a comparable equivalent) for heating the chambers, the assembly can be modified to provide one or two zones of resistance heating capable of establishing a maximum power dissipation of 25 W over a 200 mm2 area; this mode can provide a ramp rate of ±10 E/sec during transition from 55 EC to 95 EC.
  • The above described structure (Section IIB) for detecting an analyte-related signal in each chamber, including the optical window associated with that chamber, is also referred to herein collectively as detection means for detecting such signal.
  • Another type of detection means is a biosensor device capable of detecting the reaction of an analyte with an analyte-specific reagent in each chamber. Amperometric biosensors suitable for use in the invention operate on a variety of principles. In one, the analyte being measured is itself capable of interacting with an analyte-specific reagent to generate an electrochemical species, i.e., a species capable of function as an electron donor or acceptor when in contact with an electrode. As an example, reaction of the analyte cholesterol with the reagent cholesterol oxidase generates the electrochemical species H2O2 which, in contact with an electrode, produces a measurable current in a circuit containing the electrode.
  • The analyte-specific reagent may be localized on a film separated from the electrode surface by a permselective layer that is selectively permeable to the electrochemical species (and other small components in the sample). When sample fluid is added to the biosensor, reaction of the analyte with the corresponding reagent produces an electrochemical species whose presence and amount are quantitated by current measurement through the electrode.
  • Alternatively, the analyte-specific reagent may be a receptor which is specific for the analyte. Initially, the receptor sites are filled with an analyte-enzyme conjugate. In the presence of analyte, the conjugates are displaced from the receptor, and are then free to migrate to positions close to the electrode, for production of transient electrochemical species (such as H2O2 in the presence of catalase) in the vicinity of the electrode.
  • Another general type of biosensor employs a lipid bilayer membrane as a gate for electrochemical species interposed between a sample-fluid chamber and an electrode. The bilayer is provided with ion-channel proteins which function as ion gates that can be opened by analyte binding to the proteins. Thus, binding of analyte to the channel proteins (which serve as the analyte-specific reagent) leads to ion flow across the membrane and detectable signal at the electrode.
  • Thin-film biosensors of the type mentioned above may be formed in a microchip or small-substrate format by photolithographic methods, such as described in U.S. Pat. Nos. 5,391,250, 5,212050, 5,200,051, and 4,975,175. As applied to the present invention, the chamber walls in the substrate may serve as the substrate for deposition of the required electrode and film layers. In addition to these layers, suitable conductive connectors connecting the electrodes to electrical leads are also laid down.
  • In a typical device, each chamber contains a biosensor for a given analyte. When sample is introduced into the device, the multiple sample analytes are then separately measured in the chambers, with the results being reported to a processing unit to which the device is electrically connected.
  • Assay Method
  • In another aspect, the invention includes a method for detecting or quantitating a plurality of analytes in a liquid sample. In the method, there is provided a device of the type described above, wherein the interior of the network is placed under vacuum. A liquid sample is then applied to the inlet, and the sample is allowed to be drawn into the sample-distribution network by vacuum action, delivering sample to the detection chambers. The delivered sample is allowed to react with the analyte-specific reagent in each detection chamber under conditions effective to produce a detectable signal when the selected analyte is present in the sample. The reaction chambers are inspected or analyzed to determine the presence and/or amount of the selected analytes in the sample.
  • The sample tested may be from any source which can be dissolved or extracted into a liquid that is compatible with the device, and which may potentially contain one or more of the analytes of interest. For example, the sample may be a biological fluid such as blood, serum, plasma, urine, sweat, tear fluid, semen, saliva, cerebral spinal fluid, or a purified or modified derivative thereof. The sample may also be obtained from a plant, animal tissue, cellular lysate, cell culture, microbial sample, or soil sample, for example. The sample may be purified or pre-treated if necessary before testing, to remove substances that might otherwise interfere with analyte detection. Typically, the sample fluid will be an aqueous solution, particularly for polar analytes such as polypeptides, polynucleotides, and salts, for example. The solution may include surfactants or detergents to improve analytes solubility. For non-polar and hydrophobic analytes, organic solvents may be more suitable.
  • As discussed above, the device may be manufactured and sold in a form wherein the sample-distribution network is under vacuum, so that the device is ready to load by the end-user. Alternatively, evacuation of the network is conducted by the user, through a vacuum port or via the sample inlet itself.
  • Prior to sample loading, any gas in the network may be replaced with another gas, according to the requirements of the assay. In a preferred embodiment, the residual gas is replaced with carbon dioxide, so that any gas bubbles that appear in the network after sample loading are quickly dissolved by the sample fluid, particularly if the sample is an aqueous solution.
  • It will be appreciated that when the device includes a vacuum port downstream of the detection chambers, the sample delivery channels in the device may be cleared of sample after the detection chambers have been filled, to further isolate the detection chambers from each other. The invention also contemplates filling the delivery channels with an additional fluid, such as a mineral oil or a viscous polymer solution containing agarose or other viscous material (e.g., see Dubrow, U.S. Pat. No. 5,164,055, and Menchen et al., U.S. Pat. No. 5,290,418), to segregate the chambers from each other, or with a reagent-containing solution which facilitates the assay.
  • In a particularly advantageous embodiment of the invention, a large-volume syringe can be used to generate a vacuum inside the sample distribution network of the device prior to loading. By “large-volume” is meant that the volume of the syringe is greater than the total internal volume of the device (i.e., of the sample distribution network). Preferably, the volume of the syringe is at least 20-fold greater than the interior volume of the device. With reference to the device in FIG. 9, the inlet-tip of the syringe is connected to vacuum port 212. When opening 216 is aligned with opening 179, the syringe is used to draw air from the interior of the device, thereby lowering the internal pressure. For example, if a syringe with a volume of 50 mL is used, and the internal volume of the device is 100 μL, the pressure in the sample distribution network can be reduced by a factor of 500 (=0.1 mL/50 mL). Thus, an initial internal pressure of 760 torr can be reduced to less than 2 torr. With reference to the device in FIG. 6A, the syringe can be connected to fitting 106 or 102 using appropriate connections, to withdraw air from the distribution network.
  • Accordingly, the present invention includes a kit comprising (i) a device as described above and (ii) a syringe for drawing air from the interior of the device. The invention also includes a method of using the kit to detect one or more analytes in a sample, as described above. It will be appreciated that using a syringe greatly simplifies the step of creating a vacuum inside the device, so that the device can be used quickly or immediately without needing a mechanical vacuum pump.
  • Utility
  • The present invention can be used in a wide variety of applications. The invention can be used for medical or veterinary purposes, such as detecting pathogens, diagnosing or monitoring disease, genetic screening, determining antibody or antigen titers, detecting and monitoring changes in health, and monitoring drug therapy. The invention is also useful in a wide variety of forensic, environmental, and industrial applications, including screening drug candidates for activity.
  • More generally, the present invention provides a convenient method for simultaneous assay of multiple analytes in a sample. The invention is highly flexible in its applications, being adaptable to analysis of a wide variety of analytes and sample materials. By providing pre-dispensed, analyte-specific reagents in separate detection chambers, the invention eliminates the need for complicated and time-consuming reagent preparation.
  • Practice of the invention is further simplified since the detection chambers can be loaded via a single sample inlet. The use of uniformly sized detection chambers renders the device self-metering, in that a precise volume of sample is delivered to each chamber. Thus, the precision, accuracy, and reproducibility of the assay are all enhanced, since the quantities and compositions of the analyte-specific reagents, the quantity of sample in the chambers, and the reaction conditions can be carefully controlled. Moreover, very small volumes of sample are required since the dimensions of the sample-distribution network in the device can be very small.
  • The device may be formed from a wide variety of materials, allowing the composition of the device to be adapted to the particular reagents and conditions in the assay. Inasmuch as the device requires no moving parts, and can be relatively small in size (typically having dimension on the order of millimeters to centimeters), manufacture of the device is simplified and costs are reduced.
  • The features and advantages of the invention may be further understood from the following example, which is not intended in any way to limit the scope of the invention.
  • Example
  • The following study was performed using a polycarbonate microdevice substantially as shown in FIG. 9, to demonstrate detection of a human β-actin gene by PCR (polymerase chain reaction). The assay components for PCR detection were obtained from PE Applied Biosystems (Foster City, Calif., β-actin kit, part #N808-0230). The kit components included the following stock solutions:
  • β-Actin Forward Primer:
  • 3 μM primer in 10 mM Tris-HCl, pH 8.0 (at room temperature), 1 mM EDTA
  • β-Actin Reverse Primer:
  • 3 μM primer in 10 mM Tris-HCl, pH 8.0 (at room temperature), 1 mM EDTA
  • β-Actin Probe:
  • 2 μM TAMRA-labeled probe in 10 mM Tris-HCl, pH 8.0 (at room temperature), 1 mM EDTA
  • DNA Sample:
  • 370 μg/mL human genomic DNA in 10 mM Tris-HCl, pH 8.0 (at room temperature), 1 mM EDTA (from Coriell Cell Repositories, Camden, N.J.)
  • dNTPs:
  • 20 mM dNTP (1 tube each for dUTP, dATP, dCTP and dGTP) in autoclaved deionized ultrafiltered water, titrated to pH 7.0 with NaOH
  • DNA Polymerase:
  • “AMPLITAQ GOLD” DNA polymerase at 5 U/μL, from PE Applied Biosystems, part #N808-0240 (PE Applied Biosystems “AMPLITAQ GOLD” Product Brochure, 1996)
  • “AMPERASE” UNG:
  • uracil-N-glycosylase at 1 U/μL, from PE Applied Biosystems, part #N808-0096
  • 10× “TAQMAN” Buffer A:
  • 500 mM KCl, 100 mM Tris-HCl, 0.1 M EDTA, 600 nM Passive Reference 1 (ROX), pH 8.3 at room temperature, autoclaved
  • MgCl2:
  • 20 mM MgCl2 in autoclaved deionized ultrafiltered water
  • A description of the sequences of the forward primer, the reverse primer, and the TAMRA-labeled probe can be found in PE Applied Biosystems “TAQMAN” PCR Reagent Protocol (1996), which also describes the general steps of the “TAQMAN” assay technique. The forward and reverse primers were effective to produce a 297 basepair PCR product.
  • A flat substrate layer 180 and a substrate layer 161 were formed from polycarbonate by standard injection-molding methods (substrate layer 161) or from sheet stock (layer 180). The volume of each detection chamber was 1 μL.
  • Detection chambers were loaded with different amounts of forward primer, reverse primer, and fluorescent probe as follows. To a polypropylene tube was added 0.5 mL each of β-actin forward primer solution, reverse primer solution, and fluorescent probe, to give a final primer/probe stock solution volume of 1.5 mL. This solution was then loaded into alternating detection chambers in substrate layer 161 using a robotically controlled microsyringe. Specifically, alternate chambers were loaded with either a 1×, 5× or 10× amount of primer/probe solution, with 1× (14 nL primer/probe stock solution) being equivalent to a final concentration in a detection chamber of 15 nM of each primer and 10 nM of fluorescent probe (after the dried chamber is subsequently filled with sample), 5× (72 nL primer/probe stock solution) being equivalent to a final concentration of 75 nM of each primer and 50 nM of fluorescent probe, and 10× (145 nL primer/probe stock solution) being equivalent to a final concentration of 150 nM of each primer and 100 nM of fluorescent probe. The amounts of primer and probe in the loaded chambers corresponded to 1/20, ¼, and ½ of the concentrations used under standard reaction conditions, for the 1×, 5×, and 10× chambers, respectively. The loaded chambers produced a “checkerboard” pattern in substrate layer 161 where each loaded chamber was separated by an intervening empty chamber.
  • After the loaded chambers were allowed to air-dry to dryness at room temperature, the loaded substrate layer (161) was joined to a flat substrate layer 180 by ultrasonic welding. Inlet fitting 190 was then placed over sample inlet 162, such that opening 179 was aligned with vacuum port opening 216. The sample distribution network 164 and detection chambers 168 were evacuated via vacuum port 212, which was connected to a vacuum pump, to a final internal pressure of approximately 1 to 10 torr.
  • The PCR reaction mixture (sample), without primers and probe, was prepared from the above stock solutions to give the following final concentrations in the sample:
  • 10 mM Tris-HCl, pH 8.3
  • 50 mM KCl
  • 3.5 mM MgCl2
  • 400 μM dUTP
  • 200 μM each dATP, dCTP, and dGTP
  • U/μL uracil-N-glycosylase
  • 0.25 U/μL “AMPLITAQ GOLD” DNA polymerase
  • 0.74 ng/μL human genomic DNA template
  • For loading of sample into the microdevice, a micropipette loaded with the above sample solution was placed in sample port 214 so as to minimize the deadvolume occupied by air at the tip of the pipette. Inlet fitting 190 was then pressed down further to align opening 179 with opening 218, so that the sample was drawn from port 214 into the detection chambers by vacuum action. Filling of the chambers was complete in less than a second.
  • The microdevice was then clamped to a pettier device (20 mm×20 mm) glued to an aluminum heat sink. Cycling was controlled using a Marlow temperature controller (Marlow Industries Inc., Dallas, Tex., Model No. SE 5020). A thermistor was attached to the peltier device to provide temperature feedback (Marlow part No. 217-2228-006). The microdevice was thermocycled as follows:
      • precycle: 50 EC for 2 minutes; 95 EC for 10 minutes;
      • 40 cycles: 95 EC for 15 seconds, 60 EC for 1 minute;
      • hold at 72 EC.
  • Signal detection was accomplished using a fluorescence detection instrument consisting of a tungsten bulb for illumination and a CCD camera and 4-color filter wheel for detection. Images of all detection chambers (wells) were taken at the end of each thermocycle (during the 60 EC step) at several wavelengths in order to monitor the increase of the reporter's fluorescence. Interfering fluorescence fluctuations were normalized by dividing the emission intensity of the reporter dye by the emission intensity of the passive reference (ROX dye) for a given chamber. The excitation wavelength was 488 nm. The reporter intensity was measured at 518 nm, and the passive reference intensity was measured at 602 nm.
  • Results
  • Positive fluorescent signals were detected in all chambers that had been loaded with the β-actin primers and fluorescent probe at the 5× and 10 concentrations. Little or no signal was detected for chambers loaded at the 1× concentration. No detectable signal was detected above background for the chambers which did not contain β-actin primer and probe, indicating that there was no cross-contamination between detection chambers after 40 heat/cool cycles.
  • The highest final fluorescence signals were obtained in detection chambers loaded with a 10× amount of primers and probe, with detectable signals appearing after about 23 cycles. The 5× chambers also showed detectable signals after cycle 23, but the final fluorescence signal was not as high as that for the 10× wells (due to lower probe concentration). Thus, the β-actin gene was readily detected using primer and probe concentrations equal to ¼ and ½ of those used under ordinary conditions. The results also show that the preloaded primers and probes were successfully dissolved in the sample after sample loading.
  • Although the invention has been described by way of illustration and example for purposes of clarity and understanding, it will be appreciated that various modifications can be made without departing from the invention. All references cited above are incorporated herein by reference.

Claims (15)

1. A method comprising:
pre-loading a first unlabeled oligonucleotide into a chamber;
pre-loading a second unlabeled oligonucleotide into the chamber;
after the pre-loading of the first unlabeled oligonucleotide and of the second unlabeled oligonucleotide, introducing a sample comprising a target sequence into the chamber;
reacting the target sequence with both the first unlabeled oligonucleotide and the second unlabeled oligonucleotide in the chamber, to form a reaction product in the chamber;
producing a detectable signal from the reaction product in the chamber; and
detecting more than one optical signal indicative of more than one different analyte in the sample, wherein the more than one optical signal comprises the detectable signal.
2. The method of claim 1, wherein reacting the target sequence with both the first unlabeled oligonucleotide and the second unlabeled oligonucleotide in the chamber, to form a reaction product in the chamber, comprises at least one of a polymerase chain reaction, a ligase chain reaction, an oligonucleotide ligation assay, and a hybridization assay.
3. The method of claim 1, wherein the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprise a primer pair suitable for amplifying the target sequence.
4. The method of claim 1, wherein at least one of the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprises a sequence that is complementary to at least a portion of the target sequence.
5. The method of claim 1, wherein the reaction product is detected through an optically transparent window in the chamber.
6. The method of claim 1, wherein the sample is introduced into the chamber by vacuum action.
7. The method of claim 1, wherein at least one of the pre-loaded first unlabelled oligonucleotide and the pre-loaded second unlabelled oligonucleotide are dried in the chamber.
8. The method of claim 1, wherein at least one of the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprises a polynucleotide analog.
9. The method of claim 1, wherein the first unlabeled oligonucleotide and the second unlabeled oligonucleotide bind to adjacent, contiguous regions of the target sequence.
10. The method of claim 1, wherein the more than one optical signal is detected sequentially.
11. The method of claim 1, wherein the more than one optical signal is detected simultaneously.
12. The method of claim 1, wherein the more than one optical signal comprises at least two distinctive wavelengths.
13. The method of claim 1, wherein the more than one optical signal is generated by a fluorescent dyes.
14. The method of claim 1, further comprising labeling the reaction product in the chamber, with a detectable label, wherein the detecting comprises detecting an optical signal generated by the label.
15. The method of claim 14, wherein the label comprises a fluorescent label.
US11/811,476 1996-04-03 2007-06-11 Device and method for multiple analyte detection Abandoned US20110003281A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/811,476 US20110003281A1 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1471296P 1996-04-03 1996-04-03
US08/831,983 US6126899A (en) 1996-04-03 1997-04-02 Device for multiple analyte detection
US09/628,076 US7235406B1 (en) 1996-04-03 2000-07-28 Nucleic acid analysis device
US11/029,968 US7244622B2 (en) 1996-04-03 2005-01-05 Device and method for multiple analyte detection
US11/811,476 US20110003281A1 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/029,968 Continuation US7244622B2 (en) 1996-04-03 2005-01-05 Device and method for multiple analyte detection

Publications (1)

Publication Number Publication Date
US20110003281A1 true US20110003281A1 (en) 2011-01-06

Family

ID=34753548

Family Applications (16)

Application Number Title Priority Date Filing Date
US11/029,968 Expired - Fee Related US7244622B2 (en) 1996-04-03 2005-01-05 Device and method for multiple analyte detection
US11/104,156 Abandoned US20050186684A1 (en) 1996-04-03 2005-04-12 Device and method for multiple analyte detection
US11/341,732 Expired - Fee Related US7381569B2 (en) 1996-04-03 2006-01-27 Device and method for multiple analyte detection
US11/350,320 Expired - Fee Related US7381570B2 (en) 1996-04-03 2006-02-08 Device and method for multiple analyte detection
US11/362,475 Expired - Fee Related US7381571B2 (en) 1996-04-03 2006-02-24 Device and method for analyte detection
US11/400,610 Expired - Fee Related US8119423B2 (en) 1996-04-03 2006-04-07 Device and method for multiple analyte detection
US11/400,611 Expired - Fee Related US7833711B2 (en) 1996-04-03 2006-04-07 Device and method for multiple analyte detection
US11/431,363 Expired - Fee Related US8067226B2 (en) 1996-04-03 2006-05-10 Device and method for multiple analyte detection
US11/434,737 Abandoned US20060210439A1 (en) 1996-04-03 2006-05-16 Device and method for multiple analyte detection
US11/651,317 Expired - Fee Related US8062883B2 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/651,318 Abandoned US20070111299A1 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/651,321 Expired - Fee Related US8163538B2 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/807,536 Expired - Fee Related US7687280B2 (en) 1996-04-03 2007-05-29 Device and method for multiple analyte detection
US11/811,476 Abandoned US20110003281A1 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection
US11/811,504 Expired - Fee Related US8247219B2 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection
US11/811,501 Expired - Fee Related US7888108B2 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection

Family Applications Before (13)

Application Number Title Priority Date Filing Date
US11/029,968 Expired - Fee Related US7244622B2 (en) 1996-04-03 2005-01-05 Device and method for multiple analyte detection
US11/104,156 Abandoned US20050186684A1 (en) 1996-04-03 2005-04-12 Device and method for multiple analyte detection
US11/341,732 Expired - Fee Related US7381569B2 (en) 1996-04-03 2006-01-27 Device and method for multiple analyte detection
US11/350,320 Expired - Fee Related US7381570B2 (en) 1996-04-03 2006-02-08 Device and method for multiple analyte detection
US11/362,475 Expired - Fee Related US7381571B2 (en) 1996-04-03 2006-02-24 Device and method for analyte detection
US11/400,610 Expired - Fee Related US8119423B2 (en) 1996-04-03 2006-04-07 Device and method for multiple analyte detection
US11/400,611 Expired - Fee Related US7833711B2 (en) 1996-04-03 2006-04-07 Device and method for multiple analyte detection
US11/431,363 Expired - Fee Related US8067226B2 (en) 1996-04-03 2006-05-10 Device and method for multiple analyte detection
US11/434,737 Abandoned US20060210439A1 (en) 1996-04-03 2006-05-16 Device and method for multiple analyte detection
US11/651,317 Expired - Fee Related US8062883B2 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/651,318 Abandoned US20070111299A1 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/651,321 Expired - Fee Related US8163538B2 (en) 1996-04-03 2007-01-09 Device and method for multiple analyte detection
US11/807,536 Expired - Fee Related US7687280B2 (en) 1996-04-03 2007-05-29 Device and method for multiple analyte detection

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/811,504 Expired - Fee Related US8247219B2 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection
US11/811,501 Expired - Fee Related US7888108B2 (en) 1996-04-03 2007-06-11 Device and method for multiple analyte detection

Country Status (1)

Country Link
US (16) US7244622B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080105549A1 (en) * 2002-09-24 2008-05-08 Pamela Vamsee K Methods for performing microfluidic sampling
US20080138815A1 (en) * 1997-04-17 2008-06-12 Cytonix Method of loading sample into a microfluidic device
US20090260988A1 (en) * 2002-09-24 2009-10-22 Duke University Methods for Manipulating Droplets by Electrowetting-Based Techniques
US8048628B2 (en) 2002-09-24 2011-11-01 Duke University Methods for nucleic acid amplification on a printed circuit board
US8268246B2 (en) 2007-08-09 2012-09-18 Advanced Liquid Logic Inc PCB droplet actuator fabrication
US20130209326A1 (en) * 2012-02-13 2013-08-15 Molecular Systems Corporation Microfluidic cartridge for processing and detecting nucleic acids
US9382532B2 (en) 2012-10-25 2016-07-05 Neumodx Molecular, Inc. Method and materials for isolation of nucleic acid materials
US9604213B2 (en) 2012-02-13 2017-03-28 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US9637775B2 (en) 2012-02-13 2017-05-02 Neumodx Molecular, Inc. System and method for processing biological samples
US11485968B2 (en) 2012-02-13 2022-11-01 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US11648561B2 (en) 2012-02-13 2023-05-16 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US11931740B2 (en) 2020-02-19 2024-03-19 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244622B2 (en) * 1996-04-03 2007-07-17 Applera Corporation Device and method for multiple analyte detection
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US7829025B2 (en) 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
WO2004089085A2 (en) * 2003-04-04 2004-10-21 Organ Recovery Systems, Inc. Device for separating gas from a liquid path
EP1654066B1 (en) 2003-07-31 2014-11-12 Handylab, Inc. Processing particle-containing samples
DE102004005193B4 (en) * 2004-02-02 2006-08-24 Medion Diagnostics Gmbh Device for separating individual particles from particle agglutinations
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
KR100637069B1 (en) * 2004-07-24 2006-10-23 삼성전자주식회사 Sample processing apparatus using vacant chamber and method the same
US20060078471A1 (en) * 2004-10-12 2006-04-13 Witty Thomas R Apparatus and method for a precision flow assay
US8986614B2 (en) * 2010-02-23 2015-03-24 Rheonix, Inc. Self-contained biological assay apparatus, methods, and applications
WO2007011867A2 (en) * 2005-07-15 2007-01-25 Applera Corporation Fluid processing device and method
US7329860B2 (en) * 2005-11-23 2008-02-12 Illumina, Inc. Confocal imaging methods and apparatus
US20070224702A1 (en) * 2006-03-22 2007-09-27 Gyros Patent Ab Flex Method
US8883490B2 (en) 2006-03-24 2014-11-11 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
WO2007112114A2 (en) 2006-03-24 2007-10-04 Handylab, Inc. Integrated system for processing microfluidic samples, and method of using same
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US20070224088A1 (en) * 2006-03-24 2007-09-27 Applera Corporation Fluid processing device including output interface with analyzer
US20070259366A1 (en) * 2006-05-03 2007-11-08 Greg Lawrence Direct printing of patterned hydrophobic wells
US7674616B2 (en) * 2006-09-14 2010-03-09 Hemosense, Inc. Device and method for measuring properties of a sample
US20100105025A1 (en) * 2006-10-12 2010-04-29 Engelhard Eric K Devices for generating detectable polymers
WO2008127363A2 (en) * 2006-10-12 2008-10-23 Fair Isaac Corporation Devices for generating detectable polymers
US20080124710A1 (en) * 2006-10-12 2008-05-29 Engelhard Eric K Devices for generating detectable polymers
US7521189B2 (en) * 2006-10-12 2009-04-21 Fair Isaac Corporation Devices for generating detectable polymers
US7582433B2 (en) * 2006-10-12 2009-09-01 Fair Isaac Corporation Devices for generating detectable polymers
US20080090229A1 (en) * 2006-10-12 2008-04-17 Engelhard Eric K Devices for generating detectable polymers
WO2008061165A2 (en) 2006-11-14 2008-05-22 Handylab, Inc. Microfluidic cartridge and method of making same
CN1996009B (en) * 2007-01-10 2010-05-19 博奥生物有限公司 Microfluid device for multi-sample analysis and application method therefor
US20080297169A1 (en) * 2007-05-31 2008-12-04 Greenquist Alfred C Particle Fraction Determination of A Sample
CN101970111B (en) * 2007-06-21 2013-09-11 简·探针公司 Instrument and receptacles for performing processes
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US8324372B2 (en) 2007-07-13 2012-12-04 Handylab, Inc. Polynucleotide capture materials, and methods of using same
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
US8564574B2 (en) * 2007-09-18 2013-10-22 Acer Incorporated Input apparatus with multi-mode switching function
US7964170B2 (en) * 2007-10-19 2011-06-21 Fluegen, Inc. Method and apparatus for the removal of carbon dioxide from a gas stream
US20100074828A1 (en) * 2008-01-28 2010-03-25 Fluegen, Inc. Method and Apparatus for the Removal of Carbon Dioxide from a Gas Stream
US9161798B2 (en) * 2008-02-01 2015-10-20 Dfine, Inc. Bone treatment systems and methods
EP2263092A4 (en) * 2008-03-31 2014-01-22 Agency Science Tech & Res Fluid processing and transfer using inter-connected multi-chamber device
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
EP2147981A1 (en) * 2008-07-25 2010-01-27 Biotype AG Kit and method for evaluating detection properties in amplification reactions
WO2010080236A1 (en) 2008-12-19 2010-07-15 3M Innovative Properties Company System and method for processing samples
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
TW201103626A (en) * 2009-04-28 2011-02-01 Corning Inc Microreactors with connectors sealed thereon; their manufacture
US20110052446A1 (en) 2009-08-31 2011-03-03 Life Technologies Corporation Flow cells and methods of filling and using same
EP2311565A1 (en) 2009-10-14 2011-04-20 F. Hoffmann-La Roche AG Method, structure, device, kit and system for the automated analysis of liquid samples
GB201002627D0 (en) 2010-02-16 2010-03-31 Loxbridge Res Llp Aptamer based analyte detection method
US9102979B2 (en) 2010-02-23 2015-08-11 Rheonix, Inc. Self-contained biological assay apparatus, methods, and applications
WO2011106315A1 (en) * 2010-02-23 2011-09-01 Rheonix, Inc. Self-contained biological assay apparatus, methods, and applications
US9182353B2 (en) 2010-07-22 2015-11-10 Hach Company Lab-on-a-chip for alkalinity analysis
EP2436446B1 (en) 2010-10-04 2016-09-21 F. Hoffmann-La Roche AG Multi-chamber plate and method for filling it with a sample fluid
EP2652659B1 (en) 2010-12-14 2020-04-15 Life Technologies Corporation Systems and methods for run-time sequencing run quality monitoring
GB201021499D0 (en) 2010-12-20 2011-02-02 Loxbridge Res Llp Detection of quantative genetic differnces
WO2012142516A1 (en) 2011-04-15 2012-10-18 Becton, Dickinson And Company Scanning real-time microfluidic thermo-cycler and methods for synchronized thermocycling and scanning optical detection
US10466160B2 (en) 2011-08-01 2019-11-05 Celsee Diagnostics, Inc. System and method for retrieving and analyzing particles
ES2797448T3 (en) 2011-08-01 2020-12-02 Bio Rad Laboratories Cell capture system
US9352312B2 (en) 2011-09-23 2016-05-31 Alere Switzerland Gmbh System and apparatus for reactions
AU2012315595B2 (en) 2011-09-30 2015-10-22 Becton, Dickinson And Company Unitized reagent strip
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
CN104040238B (en) * 2011-11-04 2017-06-27 汉迪拉布公司 Polynucleotides sample preparation apparatus
US9382569B1 (en) 2012-01-17 2016-07-05 Elemental Scientific, Inc. Fast detection of the presence of a target microbe in a liquid sample
BR112014018995B1 (en) 2012-02-03 2021-01-19 Becton, Dickson And Company systems to perform automated testing
US9063121B2 (en) 2012-05-09 2015-06-23 Stat-Diagnostica & Innovation, S.L. Plurality of reaction chambers in a test cartridge
US9180449B2 (en) 2012-06-12 2015-11-10 Hach Company Mobile water analysis
KR102054678B1 (en) * 2012-07-12 2020-01-22 삼성전자주식회사 Fluid analysis cartridge
USD768872S1 (en) 2012-12-12 2016-10-11 Hach Company Cuvette for a water analysis instrument
WO2014100150A1 (en) * 2012-12-20 2014-06-26 Flir Detection, Inc. Device and methods for detection of analytes including use of a clorimetric barcode
US9606102B2 (en) 2013-01-26 2017-03-28 Denovo Sciences, Inc. System and method for capturing and analyzing cells
US9888283B2 (en) 2013-03-13 2018-02-06 Nagrastar Llc Systems and methods for performing transport I/O
USD758372S1 (en) * 2013-03-13 2016-06-07 Nagrastar Llc Smart card interface
US10391490B2 (en) * 2013-05-31 2019-08-27 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells
US20140363838A1 (en) * 2013-06-11 2014-12-11 William Marsh Rice University Microperfusion imaging platform
US10227544B2 (en) 2013-08-15 2019-03-12 Infineum International Limited Automotive transmission fluid compositions for improved energy efficiency
KR101506147B1 (en) * 2013-12-13 2015-03-26 삼성전자 주식회사 Reagent set, test method of sample, microfluidic device and test apparatus
KR102161058B1 (en) * 2013-12-24 2020-09-29 삼성전자주식회사 Optical detection apparatus and method of compensating detection error
US10195610B2 (en) 2014-03-10 2019-02-05 Click Diagnostics, Inc. Cartridge-based thermocycler
EP4029606A1 (en) 2014-12-31 2022-07-20 Visby Medical, Inc. Molecular diagnostic testing
US10378944B2 (en) * 2015-04-02 2019-08-13 Lin Sun Water intake tracker for a container
USD864968S1 (en) 2015-04-30 2019-10-29 Echostar Technologies L.L.C. Smart card interface
US9933196B2 (en) * 2015-05-02 2018-04-03 Ali Reza Ghiasvand System and method for simultaneous cooling and heating of sample matrix during solid and liquid phase extraction methods
JP6466598B2 (en) 2015-07-24 2019-02-06 ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. Light Guide for Fluid Test Cell
US10987674B2 (en) 2016-04-22 2021-04-27 Visby Medical, Inc. Printed circuit board heater for an amplification module
WO2017197040A1 (en) 2016-05-11 2017-11-16 Click Diagnostics, Inc. Devices and methods for nucleic acid extraction
CN110325652A (en) 2016-06-29 2019-10-11 易捷仪器诊断股份有限公司 Use the device and method of flow cell detection molecules
USD800331S1 (en) 2016-06-29 2017-10-17 Click Diagnostics, Inc. Molecular diagnostic device
USD800913S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Detection window for molecular diagnostic device
USD800914S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Status indicator for molecular diagnostic device
JP6568663B2 (en) * 2016-11-01 2019-08-28 日本板硝子株式会社 Reaction processing container, reaction processing apparatus, and reaction processing method
WO2019046307A1 (en) 2017-08-29 2019-03-07 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells
AU2018364741B2 (en) 2017-11-09 2021-03-25 Visby Medical, Inc. Portable molecular diagnostic device and methods for the detection of target viruses
US10633693B1 (en) 2019-04-16 2020-04-28 Celsee Diagnostics, Inc. System and method for leakage control in a particle capture system
US11273439B2 (en) 2019-05-07 2022-03-15 Bio-Rad Laboratories, Inc. System and method for target material retrieval from microwells
CA3138881A1 (en) 2019-05-07 2020-11-12 Bio-Rad Laboratories, Inc. System and method for automated single cell processing
US20210079331A1 (en) * 2019-09-16 2021-03-18 Delta Electronics, Inc. Biological detection cartridge and method for performing the same
WO2023028667A1 (en) * 2021-09-06 2023-03-09 Haemograph Pty Ltd Reagent pre-loading system and measuring device

Citations (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088847A (en) * 1957-07-25 1963-05-07 Union Carbide Corp Aminoalkyl silicon compounds as bonding agents for resins to metals
US3963355A (en) * 1972-05-22 1976-06-15 Mcdonnell Douglas Corporation Process and apparatus for analyzing specimens for the presence of microorganisms therein
US4038151A (en) * 1976-07-29 1977-07-26 Mcdonnell Douglas Corporation Card for use in an automated microbial detection system
US4101356A (en) * 1976-11-05 1978-07-18 Progress Processing Limited Metal coating process
US4305720A (en) * 1979-08-20 1981-12-15 Becton Dickinson & Company Gentamicin assay and products therefor
US4349510A (en) * 1979-07-24 1982-09-14 Seppo Kolehmainen Method and apparatus for measurement of samples by luminescence
US4908187A (en) * 1987-04-01 1990-03-13 Endowment For Research In Human Biology, Inc. Device for diluting and mixing liquids and applications for kinetic analysis
US4975175A (en) * 1987-03-27 1990-12-04 Isao Karube Miniaturized oxygen electrode and miniaturized biosensor and production process thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5164055A (en) * 1990-01-29 1992-11-17 Applied Biosystems, Inc. High-viscosity polymer matrix and methods
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5212050A (en) * 1988-11-14 1993-05-18 Mier Randall M Method of forming a permselective layer
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5245410A (en) * 1989-07-25 1993-09-14 Cables De Communicaciones S.A. Optical fiber sensor based on the excitation of surface plasmon
US5252294A (en) * 1988-06-01 1993-10-12 Messerschmitt-Bolkow-Blohm Gmbh Micromechanical structure
US5270183A (en) * 1991-02-08 1993-12-14 Beckman Research Institute Of The City Of Hope Device and method for the automated cycling of solutions between two or more temperatures
US5290418A (en) * 1992-09-24 1994-03-01 Applied Biosystems, Inc. Viscous electrophoresis polymer medium and method
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5443890A (en) * 1991-02-08 1995-08-22 Pharmacia Biosensor Ab Method of producing a sealing means in a microfluidic structure and a microfluidic structure comprising such sealing means
US5455008A (en) * 1992-10-16 1995-10-03 Thomas Jefferson University Apparatus for robotically performing sanger dideoxynucleotide DNA sequencing reactions using controlled pipet
US5455175A (en) * 1990-06-04 1995-10-03 University Of Utah Research Foundation Rapid thermal cycling device
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5500073A (en) * 1994-06-30 1996-03-19 International Business Machines Corporation Real time measurement of etch rate during a chemical etching process
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5585242A (en) * 1992-04-06 1996-12-17 Abbott Laboratories Method for detection of nucleic acid using total internal reflectance
US5589350A (en) * 1992-11-06 1996-12-31 Biolog, Inc. Testing device for liquid and liquid suspended samples
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US5616478A (en) * 1992-10-14 1997-04-01 Chetverin; Alexander B. Method for amplification of nucleic acids in solid media
US5620845A (en) * 1988-06-06 1997-04-15 Ampcor, Inc. Immunoassay diagnostic kit
US5639612A (en) * 1992-07-28 1997-06-17 Hitachi Chemical Company, Ltd. Method for detecting polynucleotides with immobilized polynucleotide probes identified based on Tm
US5645801A (en) * 1993-10-21 1997-07-08 Abbott Laboratories Device and method for amplifying and detecting target nucleic acids
US5656506A (en) * 1990-07-13 1997-08-12 Canon Kabushiki Kaisha Dry detection reagent containing acrylamide/styrene copolymer particles immobilizing an immunologically active substance
US5658508A (en) * 1994-06-06 1997-08-19 Nippon Shokubai Co., Ltd. Method for continuously forming a synthetic stone
US5658802A (en) * 1995-09-07 1997-08-19 Microfab Technologies, Inc. Method and apparatus for making miniaturized diagnostic arrays
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5843767A (en) * 1993-10-28 1998-12-01 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
US5846727A (en) * 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
US5856174A (en) * 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5858804A (en) * 1994-11-10 1999-01-12 Sarnoff Corporation Immunological assay conducted in a microlaboratory array
US5925517A (en) * 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5948673A (en) * 1995-09-12 1999-09-07 Becton Dickinson And Company Device and method for DNA amplification and assay
US5951952A (en) * 1995-05-31 1999-09-14 Biomerieux, Inc. Test sample card
US5989638A (en) * 1992-03-31 1999-11-23 Union Carbide Chemicals & Plastics Technology Corporation Methods and apparatus for reducing air entrapment in spray application of coatings to a substrate
US6015902A (en) * 1993-06-30 2000-01-18 Abbott Laboratories Intercalators having affinity for DNA and methods of use
US6124138A (en) * 1996-04-03 2000-09-26 The Perkin-Elmer Corporation Method for multiple analyte detection
US6334980B1 (en) * 1995-09-07 2002-01-01 Microfab Technologies Inc. Flexible apparatus with ablation formed chamber(s) for conducting bio-chemical analyses
US20020192664A1 (en) * 1985-02-26 2002-12-19 Thermo Biostar, Inc. Devices and methods for optical detection of nucleic acid hybridization
US20030152994A1 (en) * 1996-04-03 2003-08-14 Applera Corporation Device and method for multiple analyte detection
US6627159B1 (en) * 2000-06-28 2003-09-30 3M Innovative Properties Company Centrifugal filling of sample processing devices
US20030198984A1 (en) * 1995-06-07 2003-10-23 Yeasing Yang Hybridization assay probes and methods for detecting the presence of Neisseria meningitidis subtypes A,C and L in a sample
US20050019902A1 (en) * 1995-09-28 2005-01-27 Mathies Richard A. Miniaturized integrated nucleic acid processing and analysis device and method
US6953676B1 (en) * 1992-05-01 2005-10-11 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US20050282156A1 (en) * 1995-06-07 2005-12-22 Affymetrix, Inc. Methods for making a device for concurrently processing multiple biological chip assays
US20060128007A1 (en) * 1996-04-03 2006-06-15 Applera Corporation Device and method for multiple analyte detection
US7235406B1 (en) * 1996-04-03 2007-06-26 Applera Corporation Nucleic acid analysis device
US20080108074A1 (en) * 1993-09-27 2008-05-08 Drmanac Radoje T Methods and Compositions for Efficient Nucleic Acid Sequencing

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US554553A (en) * 1896-02-11 Washing-machine
US4235406A (en) * 1978-11-22 1980-11-25 Hunter Douglas International N.V. Support bracket for a venetian blind
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US5164506A (en) * 1988-12-14 1992-11-17 Bayer Aktiengesellschaft Substituted 2-pyridones and pyrid-2-thiones compounds
US5629158A (en) * 1989-03-22 1997-05-13 Cemu Bitecknik Ab Solid phase diagnosis of medical conditions
US5252296A (en) 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
US5028392A (en) 1990-06-14 1991-07-02 Alcan International Ltd. Melt process for the production of metal-matrix composite materials with enhanced particle/matrix wetting
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5182082A (en) 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
DE4138754C2 (en) * 1991-11-26 1998-10-22 Bayer Ag Polycarbonate laundry
JP2973695B2 (en) * 1992-03-12 1999-11-08 船井電機株式会社 In-vehicle navigation system
AU674685B2 (en) 1992-05-01 1997-01-09 Trustees Of The University Of Pennsylvania, The Fluid handling in microfabricated analytical devices
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US6001568A (en) 1992-10-26 1999-12-14 Institut Belka Solid medium for amplification and expression of nucleic acids as colonies
US5370183A (en) * 1993-08-11 1994-12-06 Atlantic Richfield Company Well casing guide string and repair method
CA2129787A1 (en) 1993-08-27 1995-02-28 Russell G. Higuchi Monitoring multiple amplification reactions simultaneously and analyzing same
US5591643A (en) 1993-09-01 1997-01-07 Abaxis, Inc. Simplified inlet channels
US5409665A (en) 1993-09-01 1995-04-25 Abaxis, Inc. Simultaneous cuvette filling with means to isolate cuvettes
WO1995021382A2 (en) 1994-02-01 1995-08-10 Fields Robert E Molecular analyzer and method of use
DE4415310A1 (en) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptides
US5595712A (en) 1994-07-25 1997-01-21 E. I. Du Pont De Nemours And Company Chemical mixing and reaction apparatus
US6001229A (en) 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
US5500071A (en) * 1994-10-19 1996-03-19 Hewlett-Packard Company Miniaturized planar columns in novel support media for liquid phase analysis
US5587589A (en) * 1995-03-22 1996-12-24 Motorola Two dimensional organic light emitting diode array for high density information image manifestation apparatus
FR2732518B1 (en) * 1995-03-29 1997-04-30 Entrelec Sa CONNECTION ARRANGEMENT FOR ELECTRICAL CONDUCTIVE WIRES AND MODULE, IN PARTICULAR OF THE JUNCTION BLOCK TYPE, EQUIPPED WITH SUCH AN ARRANGEMENT
US5658506A (en) * 1995-12-27 1997-08-19 Ford Global Technologies, Inc. Methods of making spray formed rapid tools
US5809242A (en) * 1996-04-19 1998-09-15 Juno Online Services, L.P. Electronic mail system for displaying advertisement at local computer received from remote system while the local computer is off-line the remote system
US5700821A (en) * 1996-07-30 1997-12-23 University Of Pittsburgh Phosphatase inhibitors and methods of use thereof
US6125899A (en) * 1997-02-17 2000-10-03 The Yokohama Rubber Co., Ltd. Heavy duty pneumatic radial tire for running on rough ground surface
US6354980B1 (en) * 1997-11-10 2002-03-12 Frederic Francis Grant Automatic transmission systems for humanly powered vehicles
JP4789320B2 (en) * 2000-12-01 2011-10-12 富士通株式会社 Semiconductor optical amplifier
US6835047B2 (en) * 2001-11-13 2004-12-28 Michigan Wheel Corporation Labyrinth seal adapter for marine propeller

Patent Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088847A (en) * 1957-07-25 1963-05-07 Union Carbide Corp Aminoalkyl silicon compounds as bonding agents for resins to metals
US3963355A (en) * 1972-05-22 1976-06-15 Mcdonnell Douglas Corporation Process and apparatus for analyzing specimens for the presence of microorganisms therein
US4038151A (en) * 1976-07-29 1977-07-26 Mcdonnell Douglas Corporation Card for use in an automated microbial detection system
US4101356A (en) * 1976-11-05 1978-07-18 Progress Processing Limited Metal coating process
US4349510A (en) * 1979-07-24 1982-09-14 Seppo Kolehmainen Method and apparatus for measurement of samples by luminescence
US4305720A (en) * 1979-08-20 1981-12-15 Becton Dickinson & Company Gentamicin assay and products therefor
US20020192664A1 (en) * 1985-02-26 2002-12-19 Thermo Biostar, Inc. Devices and methods for optical detection of nucleic acid hybridization
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4975175A (en) * 1987-03-27 1990-12-04 Isao Karube Miniaturized oxygen electrode and miniaturized biosensor and production process thereof
US4908187A (en) * 1987-04-01 1990-03-13 Endowment For Research In Human Biology, Inc. Device for diluting and mixing liquids and applications for kinetic analysis
US5252294A (en) * 1988-06-01 1993-10-12 Messerschmitt-Bolkow-Blohm Gmbh Micromechanical structure
US5620845A (en) * 1988-06-06 1997-04-15 Ampcor, Inc. Immunoassay diagnostic kit
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5212050A (en) * 1988-11-14 1993-05-18 Mier Randall M Method of forming a permselective layer
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5245410A (en) * 1989-07-25 1993-09-14 Cables De Communicaciones S.A. Optical fiber sensor based on the excitation of surface plasmon
US5164055A (en) * 1990-01-29 1992-11-17 Applied Biosystems, Inc. High-viscosity polymer matrix and methods
US5455175A (en) * 1990-06-04 1995-10-03 University Of Utah Research Foundation Rapid thermal cycling device
US5656506A (en) * 1990-07-13 1997-08-12 Canon Kabushiki Kaisha Dry detection reagent containing acrylamide/styrene copolymer particles immobilizing an immunologically active substance
US5270183A (en) * 1991-02-08 1993-12-14 Beckman Research Institute Of The City Of Hope Device and method for the automated cycling of solutions between two or more temperatures
US5443890A (en) * 1991-02-08 1995-08-22 Pharmacia Biosensor Ab Method of producing a sealing means in a microfluidic structure and a microfluidic structure comprising such sealing means
US5989638A (en) * 1992-03-31 1999-11-23 Union Carbide Chemicals & Plastics Technology Corporation Methods and apparatus for reducing air entrapment in spray application of coatings to a substrate
US5585242A (en) * 1992-04-06 1996-12-17 Abbott Laboratories Method for detection of nucleic acid using total internal reflectance
US5427946A (en) * 1992-05-01 1995-06-27 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US6953676B1 (en) * 1992-05-01 2005-10-11 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5639612A (en) * 1992-07-28 1997-06-17 Hitachi Chemical Company, Ltd. Method for detecting polynucleotides with immobilized polynucleotide probes identified based on Tm
US5290418A (en) * 1992-09-24 1994-03-01 Applied Biosystems, Inc. Viscous electrophoresis polymer medium and method
US5616478A (en) * 1992-10-14 1997-04-01 Chetverin; Alexander B. Method for amplification of nucleic acids in solid media
US5455008A (en) * 1992-10-16 1995-10-03 Thomas Jefferson University Apparatus for robotically performing sanger dideoxynucleotide DNA sequencing reactions using controlled pipet
US5589350A (en) * 1992-11-06 1996-12-31 Biolog, Inc. Testing device for liquid and liquid suspended samples
US6015902A (en) * 1993-06-30 2000-01-18 Abbott Laboratories Intercalators having affinity for DNA and methods of use
US20080108074A1 (en) * 1993-09-27 2008-05-08 Drmanac Radoje T Methods and Compositions for Efficient Nucleic Acid Sequencing
US5645801A (en) * 1993-10-21 1997-07-08 Abbott Laboratories Device and method for amplifying and detecting target nucleic acids
US5843767A (en) * 1993-10-28 1998-12-01 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
US5925517A (en) * 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5658508A (en) * 1994-06-06 1997-08-19 Nippon Shokubai Co., Ltd. Method for continuously forming a synthetic stone
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5500073A (en) * 1994-06-30 1996-03-19 International Business Machines Corporation Real time measurement of etch rate during a chemical etching process
US5858804A (en) * 1994-11-10 1999-01-12 Sarnoff Corporation Immunological assay conducted in a microlaboratory array
US5951952A (en) * 1995-05-31 1999-09-14 Biomerieux, Inc. Test sample card
US20050282156A1 (en) * 1995-06-07 2005-12-22 Affymetrix, Inc. Methods for making a device for concurrently processing multiple biological chip assays
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US20030198984A1 (en) * 1995-06-07 2003-10-23 Yeasing Yang Hybridization assay probes and methods for detecting the presence of Neisseria meningitidis subtypes A,C and L in a sample
US5856174A (en) * 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US6830936B2 (en) * 1995-06-29 2004-12-14 Affymetrix Inc. Integrated nucleic acid diagnostic device
US6334980B1 (en) * 1995-09-07 2002-01-01 Microfab Technologies Inc. Flexible apparatus with ablation formed chamber(s) for conducting bio-chemical analyses
US5658802A (en) * 1995-09-07 1997-08-19 Microfab Technologies, Inc. Method and apparatus for making miniaturized diagnostic arrays
US5948673A (en) * 1995-09-12 1999-09-07 Becton Dickinson And Company Device and method for DNA amplification and assay
US20050019902A1 (en) * 1995-09-28 2005-01-27 Mathies Richard A. Miniaturized integrated nucleic acid processing and analysis device and method
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US7211443B2 (en) * 1996-04-03 2007-05-01 Applera Corporation Device and method for multiple analyte detection
US7235406B1 (en) * 1996-04-03 2007-06-26 Applera Corporation Nucleic acid analysis device
US6825047B1 (en) * 1996-04-03 2004-11-30 Applera Corporation Device and method for multiple analyte detection
US6126899A (en) * 1996-04-03 2000-10-03 The Perkins-Elmer Corporation Device for multiple analyte detection
US7888108B2 (en) * 1996-04-03 2011-02-15 Applied Biosystems, Llc Device and method for multiple analyte detection
US20060128007A1 (en) * 1996-04-03 2006-06-15 Applera Corporation Device and method for multiple analyte detection
US20060188917A1 (en) * 1996-04-03 2006-08-24 Applera Corporation Device and method for multiple analyte detection
US20060204401A1 (en) * 1996-04-03 2006-09-14 Applera Corporation Device and method for multiple analyte detection
US7833711B2 (en) * 1996-04-03 2010-11-16 Applied Biosystems, Llc Device and method for multiple analyte detection
US6124138A (en) * 1996-04-03 2000-09-26 The Perkin-Elmer Corporation Method for multiple analyte detection
US7244622B2 (en) * 1996-04-03 2007-07-17 Applera Corporation Device and method for multiple analyte detection
US20080102461A1 (en) * 1996-04-03 2008-05-01 Applera Corporation Device and method for multiple analyte detection
US20080102462A1 (en) * 1996-04-03 2008-05-01 Applera Corporation Device and method for multiple analyte detection
US20030152994A1 (en) * 1996-04-03 2003-08-14 Applera Corporation Device and method for multiple analyte detection
US7381570B2 (en) * 1996-04-03 2008-06-03 Applera Corporation Device and method for multiple analyte detection
US7381569B2 (en) * 1996-04-03 2008-06-03 Applera Corporation Device and method for multiple analyte detection
US7381571B2 (en) * 1996-04-03 2008-06-03 Applera Corporation Device and method for analyte detection
US7687280B2 (en) * 1996-04-03 2010-03-30 Applied Biosystems, Llc Device and method for multiple analyte detection
US5846727A (en) * 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
US6627159B1 (en) * 2000-06-28 2003-09-30 3M Innovative Properties Company Centrifugal filling of sample processing devices

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Eggerding et al. (Genome Res., 1995, 4:337-345) *
Ishiguro et al. (Anal. Biochem. 1995, vol. 229, p. 207-213) *
Zhu et al. (Anal Chem 1994, vol. 66, p. 1941-1948) *

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563275B2 (en) 1997-04-17 2013-10-22 Applied Biosystems, Llc Method and device for detecting the presence of a single target nucleic acid in a sample
US20080169184A1 (en) * 1997-04-17 2008-07-17 Cytonix Device having regions of differing affinities to fluid, methods of making such devices, and methods of using such devices
US8278071B2 (en) 1997-04-17 2012-10-02 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US20080171325A1 (en) * 1997-04-17 2008-07-17 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US9506105B2 (en) 1997-04-17 2016-11-29 Applied Biosystems, Llc Device and method for amplifying target nucleic acid
US20080213766A1 (en) * 1997-04-17 2008-09-04 Cytonix Method and device for detecting the presence of a single target nucleic acid in samples
US20090035759A1 (en) * 1997-04-17 2009-02-05 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US8859204B2 (en) 1997-04-17 2014-10-14 Applied Biosystems, Llc Method for detecting the presence of a target nucleic acid sequence in a sample
US7972778B2 (en) 1997-04-17 2011-07-05 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US8822183B2 (en) 1997-04-17 2014-09-02 Applied Biosystems, Llc Device for amplifying target nucleic acid
US8067159B2 (en) 1997-04-17 2011-11-29 Applied Biosystems, Llc Methods of detecting amplified product
US8551698B2 (en) 1997-04-17 2013-10-08 Applied Biosystems, Llc Method of loading sample into a microfluidic device
US8257925B2 (en) 1997-04-17 2012-09-04 Applied Biosystems, Llc Method for detecting the presence of a single target nucleic acid in a sample
US20080138815A1 (en) * 1997-04-17 2008-06-12 Cytonix Method of loading sample into a microfluidic device
US20080160525A1 (en) * 1997-04-17 2008-07-03 Cytonix Method and device for detecting the presence of a single target nucleic acid in a sample
US8048628B2 (en) 2002-09-24 2011-11-01 Duke University Methods for nucleic acid amplification on a printed circuit board
US9180450B2 (en) 2002-09-24 2015-11-10 Advanced Liquid Logic, Inc. Droplet manipulation system and method
US8394249B2 (en) 2002-09-24 2013-03-12 Duke University Methods for manipulating droplets by electrowetting-based techniques
US9638662B2 (en) 2002-09-24 2017-05-02 Duke University Apparatuses and methods for manipulating droplets
US8524506B2 (en) 2002-09-24 2013-09-03 Duke University Methods for sampling a liquid flow
US9110017B2 (en) 2002-09-24 2015-08-18 Duke University Apparatuses and methods for manipulating droplets
US8221605B2 (en) 2002-09-24 2012-07-17 Duke University Apparatus for manipulating droplets
US8388909B2 (en) 2002-09-24 2013-03-05 Duke University Apparatuses and methods for manipulating droplets
US8906627B2 (en) 2002-09-24 2014-12-09 Duke University Apparatuses and methods for manipulating droplets
US8871071B2 (en) 2002-09-24 2014-10-28 Duke University Droplet manipulation device
US20090260988A1 (en) * 2002-09-24 2009-10-22 Duke University Methods for Manipulating Droplets by Electrowetting-Based Techniques
US20080105549A1 (en) * 2002-09-24 2008-05-08 Pamela Vamsee K Methods for performing microfluidic sampling
US8349276B2 (en) 2002-09-24 2013-01-08 Duke University Apparatuses and methods for manipulating droplets on a printed circuit board
US8268246B2 (en) 2007-08-09 2012-09-18 Advanced Liquid Logic Inc PCB droplet actuator fabrication
US9050594B2 (en) 2012-02-13 2015-06-09 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US10010888B2 (en) 2012-02-13 2018-07-03 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US11717829B2 (en) 2012-02-13 2023-08-08 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US9403165B2 (en) 2012-02-13 2016-08-02 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US9433940B2 (en) 2012-02-13 2016-09-06 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US9441219B2 (en) 2012-02-13 2016-09-13 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US9452430B1 (en) 2012-02-13 2016-09-27 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US9101930B2 (en) * 2012-02-13 2015-08-11 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US11708597B2 (en) 2012-02-13 2023-07-25 Neumodx Molecular, Inc. Pin-based valve actuation system for processing biological samples
US9604213B2 (en) 2012-02-13 2017-03-28 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US9637775B2 (en) 2012-02-13 2017-05-02 Neumodx Molecular, Inc. System and method for processing biological samples
US20130209326A1 (en) * 2012-02-13 2013-08-15 Molecular Systems Corporation Microfluidic cartridge for processing and detecting nucleic acids
US9738887B2 (en) 2012-02-13 2017-08-22 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US9339812B2 (en) 2012-02-13 2016-05-17 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US10041062B2 (en) 2012-02-13 2018-08-07 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US10093963B2 (en) 2012-02-13 2018-10-09 Neumodx Molecular, Inc. System and method for processing biological samples
US10557132B2 (en) 2012-02-13 2020-02-11 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US11655467B2 (en) 2012-02-13 2023-05-23 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US11142757B2 (en) 2012-02-13 2021-10-12 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US11485968B2 (en) 2012-02-13 2022-11-01 Neumodx Molecular, Inc. Microfluidic cartridge for processing and detecting nucleic acids
US11648561B2 (en) 2012-02-13 2023-05-16 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids
US10633647B2 (en) 2012-10-25 2020-04-28 Neumodx Molecular, Inc. Method and materials for isolation of nucleic acid materials
US9540636B2 (en) 2012-10-25 2017-01-10 Neumodx Molecular, Inc. Method and materials for isolation of nucleic acid materials
US9382532B2 (en) 2012-10-25 2016-07-05 Neumodx Molecular, Inc. Method and materials for isolation of nucleic acid materials
US11931740B2 (en) 2020-02-19 2024-03-19 Neumodx Molecular, Inc. System and method for processing and detecting nucleic acids

Also Published As

Publication number Publication date
US20060204401A1 (en) 2006-09-14
US20060127939A1 (en) 2006-06-15
US20070111299A1 (en) 2007-05-17
US20060188917A1 (en) 2006-08-24
US8119423B2 (en) 2012-02-21
US20070134710A1 (en) 2007-06-14
US20080102461A1 (en) 2008-05-01
US8247219B2 (en) 2012-08-21
US7833711B2 (en) 2010-11-16
US20060183151A1 (en) 2006-08-17
US20060210439A1 (en) 2006-09-21
US20060128007A1 (en) 2006-06-15
US8062883B2 (en) 2011-11-22
US20070111300A1 (en) 2007-05-17
US20060166352A1 (en) 2006-07-27
US7244622B2 (en) 2007-07-17
US20080108068A1 (en) 2008-05-08
US8163538B2 (en) 2012-04-24
US20080102462A1 (en) 2008-05-01
US7888108B2 (en) 2011-02-15
US20050186684A1 (en) 2005-08-25
US7381570B2 (en) 2008-06-03
US8067226B2 (en) 2011-11-29
US7687280B2 (en) 2010-03-30
US7381571B2 (en) 2008-06-03
US20050158781A1 (en) 2005-07-21
US7381569B2 (en) 2008-06-03

Similar Documents

Publication Publication Date Title
US8247219B2 (en) Device and method for multiple analyte detection
US6825047B1 (en) Device and method for multiple analyte detection
US7235406B1 (en) Nucleic acid analysis device
US6124138A (en) Method for multiple analyte detection
US11697844B2 (en) Methods and systems for nucleic acid analysis and quantification
US20070003443A1 (en) Thermal-cycling pipette tip
US20050196779A1 (en) Self-contained microfluidic biochip and apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: BANK OF AMERICA, N.A, AS COLLATERAL AGENT, WASHING

Free format text: SECURITY AGREEMENT;ASSIGNOR:APPLIED BIOSYSTEMS, LLC;REEL/FRAME:021976/0001

Effective date: 20081121

AS Assignment

Owner name: APPLIED BIOSYSTEMS INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:APPLERA CORPORATION;REEL/FRAME:022660/0963

Effective date: 20080630

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:022661/0028

Effective date: 20081121

Owner name: APPLIED BIOSYSTEMS INC., CALIFORNIA

Free format text: MERGER;ASSIGNOR:APPLIED BIOSYSTEMS INC.;REEL/FRAME:022661/0015

Effective date: 20081121

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: APPLIED BIOSYSTEMS, INC., CALIFORNIA

Free format text: LIEN RELEASE;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:030182/0677

Effective date: 20100528

AS Assignment

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0684. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:037997/0551

Effective date: 20100528

Owner name: APPLIED BIOSYSTEMS, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:037997/0551

Effective date: 20100528